WO2014024090A2 - Fungal resistant plants expressing hcp5 - Google Patents

Fungal resistant plants expressing hcp5 Download PDF

Info

Publication number
WO2014024090A2
WO2014024090A2 PCT/IB2013/056244 IB2013056244W WO2014024090A2 WO 2014024090 A2 WO2014024090 A2 WO 2014024090A2 IB 2013056244 W IB2013056244 W IB 2013056244W WO 2014024090 A2 WO2014024090 A2 WO 2014024090A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
plant
hcp5
protein
seq
Prior art date
Application number
PCT/IB2013/056244
Other languages
English (en)
French (fr)
Other versions
WO2014024090A3 (en
Inventor
Holger Schultheiss
Ralf Flachmann
Original Assignee
Basf Plant Science Company Gmbh
Basf (China) Company Limited
Basf Schweiz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Plant Science Company Gmbh, Basf (China) Company Limited, Basf Schweiz Ag filed Critical Basf Plant Science Company Gmbh
Priority to US14/418,659 priority Critical patent/US10023875B2/en
Priority to CA2874985A priority patent/CA2874985A1/en
Priority to BR112015002195A priority patent/BR112015002195A2/pt
Publication of WO2014024090A2 publication Critical patent/WO2014024090A2/en
Publication of WO2014024090A3 publication Critical patent/WO2014024090A3/en
Priority to US16/012,231 priority patent/US20180291394A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance

Definitions

  • the present invention relates to a method of increasing resistance against fungal pathogens, in particular, pathogens of the order Pucciniales, for example soybean rust, in plants, plant parts, and/or plant cells. This is achieved by increasing the expression and / or activity of an HCP5 protein in a plant, plant part and / or plant cell in comparison to wild type plants, wild type plant parts and / or wild type plant cells.
  • the invention relates to transgenic plants, plant parts, and/or plant cells having an increased resistance against fungal pathogens, in particular, pathogens of the order Pucciniales, for example soybean rust, and to recombinant expression vectors comprising a sequence that is identical or homologous to a sequence encoding an HCP5 protein.
  • Resistance generally describes the ability of a plant to prevent, or at least curtail the infestation and colonization by a harmful pathogen. Different mechanisms can be discerned in the naturally occurring resistance, with which the plants fend off colonization by phytopathogen- ic organisms. These specific interactions between the pathogen and the host determine the course of infection (Schopfer and Brennicke (1999) Dephysiologie, Springer Verlag, Berlin-Heidelberg, Germany).
  • race specific resistance also called host resistance
  • a differentiation is made between compatible and incompatible interactions.
  • an interaction occurs between a virulent pathogen and a susceptible plant.
  • the pathogen survives, and may build up reproduction structures, while the host mostly dies off.
  • An incompatible interaction occurs on the other hand when the pathogen infects the plant but is inhibited in its growth before or after weak development of symptoms (mostly by the presence of R genes of the NBS-LRR family, see below). In the latter case, the plant is resistant to the respective pathogen (Schopfer and Brennicke, vide supra).
  • this type of resistance is specific for a certain strain or pathogen.
  • a defensive and specific reaction of the host to the pathogen occurs. In nature, however, this resistance is often overcome because of the rapid evolutionary development of new virulent races of the pathogens (Neu et al. (2003) American Cytopathol. Society, MPMI 16 No. 7: 626-633).
  • pathogens are plant-species specific. This means that a pathogen can induce a disease in a certain plant species, but not in other plant species (Heath (2002) Can. J. Plant Pathol. 24: 259-264).
  • the resistance against a pathogen in certain plant species is called non-host resistance.
  • the non-host resistance offers strong, broad, and permanent protec- tion from phytopathogens.
  • Genes providing non-host resistance provide the opportunity of a strong, broad and permanent protection against certain diseases in non-host plants. In particular, such a resistance works for different strains of the pathogen.
  • Fungi are distributed worldwide. Approximately 100 000 different fungal species are known to date. Thereof rusts are of great importance. They can have a complicated development cycle with up to five different spore stages (spermatium, aecidiospore, uredospore, teleuto- spore and basidiospore).
  • the first phases of the interaction between phytopathogenic fungi and their potential host plants are decisive for the colonization of the plant by the fungus.
  • the spores become attached to the surface of the plants, germinate, and the fungus penetrates the plant.
  • Fungi may penetrate the plant via existing ports such as sto- mata, lenticels, hydatodes and wounds, or else they penetrate the plant epidermis directly as the result of the mechanical force and with the aid of cell-wall-digesting enzymes.
  • Specific infection structures are developed for penetration of the plant.
  • the plant Immediately after recognition of a potential pathogen the plant starts to elicit defense reactions. Usually the presence of the pathogen is sensed via so called PAMP receptors, a class of trans-membrane receptor like kinases recognizing conserved pathogen associated molecules (e.g. flagellin or chitin). Downstream of the PAMP receptors, the phytohormones salicylic acid (SA), jasmonate (JA) and ethylene (ET) play a critical role in the regulation of the different defense reactions. Depending on the ratio of the different phytohormones, different defense reactions are elicited by the host cell. Generally SA dependent defense is linked with resistance against biotrophic pathogens, whereas JA/ET dependent defense reactions are active against necrotrophic pathogens (and insects).
  • PAMP receptors a class of trans-membrane receptor like kinases recognizing conserved pathogen associated molecules (e.g. flagellin or chitin).
  • SA phytohormones salicylic acid
  • R-genes Another more specific resistance mechanism is based on the presence of so called resistance genes (R-genes). Most R genes belong to the nucleotide-binding site-leucine-rich repeat (NBS-LRR) gene family and function in monitoring the presence of pathogen effector proteins (virulence factors; avirulence factors). After recognizing the pathogen derived proteins a strong defense reaction (mostly accompanied by a programmed cell death) is elicit- ed.
  • NSS-LRR nucleotide-binding site-leucine-rich repeat
  • the soybean rust Phakopsora pachyrhizi directly penetrates the plant epidermis. After crossing the epidermal cell, the fungus reaches the intercellular space of the mesophyll, where the fungus starts to spread through the leaves. To acquire nutrients the fungus penetrates mesophyll cells and develops haustoria inside the mesophyl cell. During the penetration process the plasmamembrane of the penetrated mesophyll cell stays intact. Therefore the soybean rust fungus establishes a biotrophic interaction with soybean.
  • the biotrophic phytopathogenic fungi such as soybean rust and all other rust fungi, depend for their nutrition on the metabolism of living cells of the plants.
  • This type of fungi belong to the group of biotrophic fungi, like other rust fungi, powdery mildew fungi or oomycete pathogens like the genus Phytophthora or Peronospora.
  • the necrotrophic phytopathogenic fungi depend for their nutrition on dead cells of the plants, e.g. species from the genus Fusari- um, Rhizoctonia or Mycospaerella. Soybean rust has occupied an intermediate position, since it penetrates the epidermis directly, whereupon the penetrated cell becomes necrotic. After the penetration, the fungus changes over to an obligatory-biotrophic lifestyle.
  • the subgroup of the biotrophic fungal pathogens which follows essentially such an infection strategy is heminecrotrohic.
  • a hemibiotrophic pathogen lives for a short period of time in a biotrophic manner and subsequently starts killing the host cell and/or host organism, i.e., changes for the rest of its life-cycle to a necrotrophic life-style.
  • Soybean rust has become increasingly important in recent times.
  • the disease may be caused by the biotrophic rusts Phakopsora pachyrhizi and Phakopsora meibomiae. They belong to the class Basidiomycota, order Uredinales, family Phakopsoraceae. Both rusts infect a wide spectrum of leguminosic host plants.
  • P. pachyrhizi also referred to as Asian rust
  • Asian rust is the more aggressive pathogen on soy (Glycine max), and is therefore, at least currently, of great importance for agriculture.
  • P. pachyrhizi can be found in nearly all tropical and subtropical soy growing regions of the world.
  • pachyrhizi is capable of infecting 31 species from 17 families of the Leguminosae under natural conditions and is capable of growing on further 60 species under controlled conditions (Sinclair et al. (eds.), Proceedings of the rust workshop (1995), National SoyaResearch Laboratory, Publication No. 1 (1996); Rytter J.L. et al., Plant Dis. 87, 818 (1984)).
  • P. meibomiae has been found in the Caribbean Basin and in Puerto Rico, and has not caused substantial damage as yet.
  • Rpp1 - 5 and Rpp?(Hyuuga) which mediate resistance of soy to P. pachyrhizi.
  • the object of the present invention is inter alia to provide a method of increasing resistance against fungal pathogens, preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably against fungal pathogens of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust.
  • rust pathogens i.e., fungal pathogens of the order Pucciniales
  • fungal pathogens of the family Phakopsoraceae more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust.
  • the present invention therefore provides a method of increasing resistance against fungal pathogens, preferably against rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably against fungal pathogens of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust, in transgenic plants, transgenic plant parts, or transgenic plant cells by overexpressing one or more HCP5 nucleic acids.
  • rust pathogens i.e., fungal pathogens of the order Pucciniales
  • fungal pathogens of the family Phakopsoraceae more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust
  • a further object is to provide transgenic plants resistant against fungal pathogens, preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust, a method for producing such plants as well as a vector construct useful for the above methods.
  • fungal pathogens preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust
  • the present invention also refers to a recombinant vector construct and a transgenic plant, transgenic plant part, or transgenic plant cell comprising an exogenous HCP5 nucleic acid. Furthermore, a method for the production of a transgenic plant, transgenic plant part or transgenic plant cell using the nucleic acid of the present invention is claimed herein. In addition, the use of a nucleic acid or the recombinant vector of the present invention for the transformation of a plant, plant part, or plant cell is claimed herein.
  • the objects of the present invention, as outlined above, are achieved by the subject-matter of the main claims. Preferred embodiments of the invention are defined by the subject matter of the dependent claims.
  • the object of the present invention is inter alia to provide a method of increasing resistance against fungal pathogens, preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably against fungal pathogens of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust.
  • rust pathogens i.e., fungal pathogens of the order Pucciniales
  • fungal pathogens of the family Phakopsoraceae more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust.
  • Phakopsoorder Pucciniales for example soybean rust, can be enhanced by increasing the expression of a HCP5 protein.
  • the present invention therefore provides a method of increasing resistance against fungal pathogens, preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), pref- erably against fungal pathogens of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust, in transgenic plants, transgenic plant parts, or transgenic plant cells by overexpressing one or more HCP5 nucleic acids.
  • rust pathogens i.e., fungal pathogens of the order Pucciniales
  • pref- erably against fungal pathogens of the family Phakopsoraceae more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known
  • a further object is to provide transgenic plants resistant against fungal pathogens, preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust, a method for producing such plants as well as a vector construct useful for the above methods.
  • fungal pathogens preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust
  • the present invention also refers to a recombinant vector construct and a transgenic plant, transgenic plant part, or transgenic plant cell comprising an exogenous HCP5 nucleic acid. Furthermore, a method for the production of a transgenic plant, transgenic plant part or transgenic plant cell using the nucleic acid of the present invention is claimed herein. In addition, the use of a nucleic acid or the recombinant vector of the present invention for the transformation of a plant, plant part, or plant cell is claimed herein.
  • Figure 1 shows the scoring system used to determine the level of diseased leaf area of wildtype and transgenic soy plants against the rust fungus P. pachyrhizi (as described in GODOY, C.V., KOGA, L.J. & CANTERI, M.G. Diagrammatic scale for assessment of soybean rust severity. Fitopatologia Brasileira 31 :063-068. 2006).
  • Figure 2 shows the schematic illustration of the plant transformation vector harboring the HCP5 nucleic acid under control of the parsley ubiquitine promoter.
  • Figure 3 shows the full-length-sequence of the HCP5 gene from Arabidopsis thaliana having SEQ ID NO: 1 .
  • Figure 4 shows the sequence of a HCP5 cDNA (accession No NM_124099) having SEQ ID NO: 2 as derived by bioinformatics from the genomic HCP5 full-length sequence.
  • Figure 5 shows the sequence of a HCP5 protein (SEQ ID NO: 3).
  • Figure 6 shows the sequence of the genomic sequence (part of accession No
  • NC_003076.8 from Arabidopsis thaliana around the region which codes for HCP5 and having SEQ ID NO: 4.
  • Figure 7 shows the alignment of the Arabidopsis genome sequence (part of accession No NC_003076.8, SEQ ID NO: 4), a HCP5 cDNA (derived by bioinformatics from the genomic sequence; accession No NM_124099, SEQ ID NO: 2), and the sequence of the HCP5 nucleic acid as shown in SEQ ID NO: 1 .
  • the genome sequence (SEQ ID NO: 4) is truncated at its 3' and 5' end. The truncated genome sequence is shown in SEQ ID NO: 5.
  • Figure 8 shows the result of the scoring of 50 transgenic soy plants (derived from 5 inde- pendent events, 10 plants per event) expressing the HCP5 overexpression vector construct.
  • Ti soybean plants expressing HCP5 protein were inoculated with spores of Phakopsora pachyrhizi. The evaluation of the diseased leaf area on all leaves was performed 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves was considered as diseased leaf area.
  • At all 50 soybean Ti plants expressing HCP5 (expression checked by RT-PCR) were evaluated in parallel to non-transgenic control plants. The average of the diseased leaf area is shown in Figure 8.
  • Overexpression of HCP5 significantly (* : p ⁇ 0.05) reduces the diseased leaf area in comparison to non-transgenic control plants by 25.1 %.
  • Figure 9 contains a brief description of the sequences of the sequence listing.
  • homologues of a protein encompass peptides, oligopeptides, polypeptides, proteins and/or enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar functional activity as the unmodified protein from which they are derived.
  • “Homologues” of a nucleic acid encompass nucleotides and/or polynucleotides having nucleic acid substitutions, deletions and/or insertions relative to the unmodified nucleic acid in question, wherein the protein coded by such nucleic acids has similar or higher functional activity as the unmodified protein coded by the unmodified nucleic acid from which they are derived.
  • homologues of a nucleic acid may encompass substitutions on the basis of the degenerative amino acid code.
  • a “deletion” refers to removal of one or more amino acids from a protein or to the removal of one or more nucleic acids from DNA, ssRNA and/or dsRNA.
  • An “insertion” refers to one or more amino acid residues or nucleic acid residues being introduced into a predetermined site in a protein or the nucleic acid.
  • substitution refers to replacement of amino acids of the protein with other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break a-helical structures or beta-sheet structures).
  • a substitution refers to a replacement of one or more nucleotides with other nucleotides in a nucleic acid, wherein the protein coded by the modified nucleic acid has a similar function.
  • homologues of a nucleic acid encompass substitutions on the basis of the degenerative amino acid code.
  • Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the protein and may range from 1 to 10 amino ac- ids; insertions or deletion will usually be of the order of about 1 to 10 amino acid residues.
  • the amino acid substitutions are preferably conservative amino acid substitutions. Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company (Eds) and Table 1 below, or Taylor W.R. (1986) The classification of amino acid conservation J Theor Biol., 1 19:205-18).
  • Amino acid substitutions, deletions and/or insertions may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulation.
  • Orthologues and paralogues encompass evolutionary concepts used to describe the ancestral relationships of genes. Paralogues are genes within the same species that have origi- nated through duplication of an ancestral gene; orthologues are genes from different organisms that have originated through speciation, and are also derived from a common ancestral gene.
  • encode or "coding for” is used for the capability of a nucleic acid to contain the information for the amino acid sequence of a protein via the genetic code, i.e., the succession of codons each being a sequence of three nucleotides, which specify which amino acid will be added next during protein synthesis.
  • the terms “encode” or “coding for” therefore includes all possible reading frames of a nucleic acid.
  • the terms “encode” or “coding for” also applies to a nucleic acid, which coding sequence is interrupted by non- coding nucleic acid sequences, which are removed prior translation, e.g., a nucleic acid sequence comprising introns.
  • domain refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other posi- tions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or function of a protein.
  • GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps.
  • the BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity or similarity or homology and performs a statistical analysis of the identity or similarity or homology between the two sequences.
  • the software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI).
  • Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage.
  • Global percentages of similarity/homology/identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul 10;4:29. MatGAT: an application that generates similarity/homology/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art.
  • specific domains may also be used.
  • sequence identity values may be determined over the entire nucleic acid or amino acid sequence or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. For local alignments, the Smith- Waterman algorithm is particularly useful (Smith TF, Waterman MS (1981 ) J. Mol. Biol 147(1 );195-7).
  • the terms "fungal-resistance”, “resistant to a fungus” and/or “fungal- resistant” mean reducing, preventing, or delaying an infection by fungi.
  • resistance refers to fungal resistance. Resistance does not imply that the plant necessarily has 100% resistance to infection. In preferred embodiments, enhancing or increasing fungal resistance means that resistance in a resistant plant is greater than 10%, greater than 20%, greater than 30%, greater than 40%, greater than 50%, greater than 60%, greater than
  • the terms “soybean rust-resistance”, “resistant to a soybean rust”, “soybean rust-resistant”, “rust-resistance”, “resistant to a rust”, or “rust-resistant” mean reducing or preventing or delaying an infection of a plant, plant part, or plant cell by Phakopsoraceae, in particular Phakopsora pachyrhizi and Phakopsora meibomiae - also known as soybean rust or Asian Soybean Rust (ASR), as compared to a wild type plant, wild type plant part, or wild type plant cell.
  • Phakopsoraceae in particular Phakopsora pachyrhizi and Phakopsora meibomiae - also known as soybean rust or Asian Soybean Rust (ASR)
  • enhancing or increasing rust resistance means that rust resistance in a resistant plant is greater than 10%, greater than 20%, greater than 30%, greater than 40%, greater than 50%, greater than 60%, greater than 70%, greater than 80%, greater than 90%, or greater than 95% in comparison to a wild type plant that is not resistant to soybean rust.
  • the wild type plant is a plant of a similar, more preferably identical, genotype as the plant having increased resistance to the soybean rust, but does not comprise an exogenous HCP5 nucleic acid, functional fragments thereof and/or an exogenous nucleic acid capable of hybridizing with an HCP5 nucleic acid.
  • the level of fungal resistance of a plant can be determined in various ways, e.g. by scoring/measuring the infected leaf area in relation to the overall leaf area. Another possibility to determine the level of resistance is to count the number of soybean rust colonies on the plant or to measure the amount of spores produced by these colonies. Another way to resolve the degree of fungal infestation is to specifically measure the amount of rust DNA by quantitative (q) PCR. Specific probes and primer sequences for most fungal pathogens are available in the literature (Frederick RD, Snyder CL, Peterson GL, et al. 2002 Polymerase chain reaction assays for the detection and discrimination of the rust pathogens Phakopso- ra pachyrhizi and P. meibomiae, Phytopathology 92(2) 217-227).
  • hybridization includes "any process by which a strand of nucleic acid molecule joins with a complementary strand through base pairing" (J. Coombs (1994) Dictionary of Biotechnology, Stockton Press, New York). Hybridization and the strength of hybridization (i.e., the strength of the association between the nucleic acid molecules) is impacted by such factors as the degree of complementarity between the nucleic acid molecules, stringency of the conditions involved, the Tm of the formed hybrid, and the G:C ratio within the nucleic acid molecules.
  • Tm is used in reference to the "melting temperature.”
  • the melting temperature is the temperature at which a population of double-stranded nucleic acid molecules becomes half dissociated into single strands.
  • stringency conditions refers to conditions, wherein 100 contigous nucleotides or more, 150 contigous nucleotides or more, 200 contigous nucleotides or more or 250 contigous nucleotides or more which are a fragment or identical to the complementary nucleic acid molecule (DNA, RNA, ssDNA or ssRNA) hybridizes under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 2 X SSC, 0.1 % SDS at 50°C or 65°C, preferably at 65°C, with a specific nucleic acid molecule (DNA; RNA, ssDNA or ss RNA).
  • SDS sodium dodecyl sulfate
  • the hybridizing conditions are equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M Na- P04, 1 mM EDTA at 50°C with washing in 1 X SSC, 0.1 % SDS at 50°C or 65°C, preferably 65°C, more preferably the hybridizing conditions are equivalent to hybridization in 7% sodi- urn dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 0,1 X SSC, 0.1 % SDS at 50°C or 65°C, preferably 65°C.
  • SDS sodium dodecyl sulfate
  • SDS sodi- urn dodecyl sulfate
  • the complementary nucleotides hybridize with a fragment or the whole HCP5 nucleic acids.
  • preferred hybridization conditions encompass hybridisation at 65°C in 1x SSC or at 42°C in 1x SSC and 50% formamide, followed by washing at 65°C in 0.3x SSC or hybridisation at 50°C in 4x SSC or at 40°C in 6x SSC and 50% formamide, followed by washing at 50°C in 2x SSC.
  • Further preferred hybridization conditions are 0.1 % SDS, 0.1 SSD and 65°C.
  • percentage of sequence identity is calculated by comparing two optimally aligned sequences over a particular region, determining the number of positions at which the identical base or amino acid occurs in both sequences in order to yield the number of matched positions, dividing the number of such positions by the total number of positions in the region being compared and multiplying the result by 100.
  • identity may be calculated by means of the Vector NTI Suite 7.1 program of the company Informax (USA) employing the Clustal Method (Higgins DG, Sharp PM.
  • the identity may be determined according to Chenna, Ramu, Sugawara, Hideaki, Koike, Tadashi, Lopez, Rodrigo, Gibson, Toby J, Higgins, Desmond G, Thompson, Julie D. Multiple sequence alignment with the Clustal series of programs. (2003) Nucleic Acids Res 31 (13):3497-500, the web page: http://www.ebi.ac.Uk/Tools/clustalw/index.html# and the following settings
  • nucleic acid sequences mentioned herein can be produced in a known way by chemical synthesis from the nucleotide building blocks, e.g. by fragment condensation of individual overlapping, complementary nucleic acid building blocks of the double helix.
  • oligonucleotides can, for example, be performed in a known way, by the phosphoamidite method (Voet, Voet, 2nd edition, Wiley Press, New York, pages 896- 897).
  • the accumulation of synthetic oligonucleotides and filling of gaps by means of the Klenow fragment of DNA polymerase and ligation reactions as well as general cloning techniques are described in Sambrook et al. (1989), see below.
  • Sequence identity between the nucleic acid or protein useful according to the present inven- tion and the HCP5 nucleic acids or HCP5 proteins may be optimized by sequence comparison and alignment algorithms known in the art (see Gribskov and Devereux, Sequence Analysis Primer, Stockton Press, 1991 , and references cited therein) and calculating the percent difference between the nucleotide or protein sequences by, for example, the Smith- Waterman algorithm as implemented in the BESTFIT software program using default parameters (e.g., University of Wisconsin Genetic Computing Group).
  • the term "plant” is intended to encompass plants at any stage of maturity or development, as well as any tissues or organs (plant parts) taken or derived from any such plant unless otherwise clearly indicated by context.
  • Plant parts include, but are not limited to, plant cells, stems, roots, flowers, ovules, stamens, seeds, leaves, embryos, meristematic regions, callus tissue, anther cultures, gametophytes, sporophytes, pollen, microspores, protoplasts, hairy root cultures, and/or the like.
  • the present invention also includes seeds produced by the plants of the present invention.
  • the seeds comprise the exogenous HCP5 nucleic acids.
  • the seeds can develop into plants with increased resistance to fungal infection as compared to a wild-type variety of the plant seed.
  • a "plant cell” includes, but is not limited to, a protoplast, gamete producing cell, and a cell that regenerates into a whole plant. Tissue culture of various tissues of plants and regeneration of plants therefrom is well known in the art and is widely published.
  • nucleic acid and / or protein refers to the nucleic acid and / or protein in question as found in a plant in its natural form (i.e., without there being any human intervention).
  • exogenous nucleic acid refers to a nucleic acid that has been introduced in a plant by means of genetechnology.
  • An "exogenous" nucleic acid can either not occur in a plant in its natural form, be different from the nucleic acid in question as found in a plant in its natural form, or can be identical to a nucleic acid found in a plant in its natural form, but integrated not within their natural genetic environment.
  • the corresponding meaning of "exogenous” is applied in the context of protein expression.
  • a transgenic plant containing a transgene, i.e., an exogenous nucleic acid may, when compared to the expression of the endogenous gene, encounter a substantial increase of the expression of the respective gene or protein in total.
  • a transgenic plant according to the present invention includes an exogenous HCP5 nucleic acid integrated at any genetic loci and optionally the plant may also include the endogenous gene within the natural genetic background.
  • nu-cleic acid sequence means with regard to, for example, a nu- cleic acid sequence, a nucleic acid molecule, an expression cassette or a vector construct comprising any one or more HCP5 nucleic acids, all those constructions brought about by man by genetechnological methods in which either
  • genetic control sequence(s) which is operably linked with the HCP5 nucleic acid se- quence according to the invention, for example a promoter, or
  • the natural genetic environment is understood as meaning the natural genomic or chromosomal locus in the original plant or the presence in a genomic library or the combination with the natural promoter.
  • a recombinant nucleic acid, expression cassette or vector construct preferably comprises a natural gene and a natural promoter, a natural gene and a non-natural promoter, a non- natural gene and a natural promoter, or a non-natural gene and a non-natural promoter.
  • the natural genetic environment of the nucleic acid sequence is preferably retained, at least in part.
  • the environment flanks the nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, most preferably at least 5000 bp.
  • a naturally occurring expression cassette for example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding nucleic acid sequence encoding a protein useful in the methods of the present invention, as defined above - becomes a recombinant expression cassette when this expression cassette is not integrated in the natural genetic environment but in a different genetic environment.
  • isolated nucleic acid or isolated protein refers to a nucleic acid or protein that is not located in its natural environment, in particular its natural cellular environment. Thus, an isolated nucleic acid or isolated protein is essentially separated from other components of its natural environment. However, the skilled person in the art is aware that preparations of an isolated nucleic acid or an isolated protein can display a certain degree of impurity depending on the isolation procedure used. Methods for purifying nucleic acids and proteins are well known in the art.
  • the isolated gene may be isolated from an organism or may be manmade, for example by chemical synthesis. In this regard, a recombinant nucleic acid may also be in an isolated form.
  • transgenic refers to an organism, e.g., a plant, plant cell, callus, plant tissue, or plant part that exogenously contains the nucleic acid, recombinant construct, vector or expression cassette described herein or a part thereof which is preferably introduced by non-essentially biological processes, preferably by Agrobacteria transformation.
  • the recombinant construct or a part thereof is stably integrated into a chromosome, so that it is passed on to successive generations by clonal propagation, vegetative propagation or sexual propagation. Preferred successive generations are transgenic too.
  • Essentially biological processes may be crossing of plants and/or natural recombination.
  • a transgenic plant, plants cell or tissue for the purposes of the invention is thus understood as meaning that an exogenous HCP5 nucleic acid, recombinant construct, vector or expression cassette including one or more HCP5 nucleic acids is integrated into the genome by means of genetechnology.
  • constructs or vectors or expression cassettes are not present in the genome of the original plant or are present in the genome of the transgenic plant not at their natural locus of the genome of the original plant.
  • a "wild type” plant, wild type” plant part, or wild type” plant cell means that said plant, plant part, or plant cell does not express exogenous HCP5 nucleic acid or exogenous HCP5 protein.
  • Natural locus means the location on a specific chromosome, preferably the location be- tween certain genes, more preferably the same sequence background as in the original plant which is transformed.
  • the transgenic plant, plant cell or tissue thereof expresses the HCP5 nucleic acids, HCP5 constructs or HCP5 expression cassettes described herein.
  • expression means the transcription of a specific gene or specific genes or specific genetic vector construct.
  • expression in particular means the transcription of a gene or genes or genetic vector construct into structural RNA (rRNA, tRNA), or mRNA with or without subsequent translation of the latter into a protein. The process includes transcription of DNA and processing of the resulting RNA product.
  • expression or “gene expression” can also include the translation of the mRNA and therewith the synthesis of the encoded protein, i.e., protein expression.
  • increased expression or “enhanced expression” or “overexpression” or “increase of content” as used herein means any form of expression that is additional to the original wild-type expression level.
  • the original wild-type expression level might also be zero (absence of expression).
  • Methods for increasing expression of genes or gene products are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression of a nucleic acid encoding the protein of interest.
  • endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, US 5,565,350; Zarling et al., W09322443), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene.
  • polyadenylation region at the 3'-end of a polynucleotide coding region.
  • the polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.
  • the 3' end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.
  • An intron sequence may also be added to the 5' untranslated region (UTR) and/or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol.
  • UTR 5' untranslated region
  • coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol.
  • Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg (1988) Mol. Cell biol. 8: 4395-4405; Callis et al. (1987) Genes Dev 1 :1 183-1200).
  • Such intron enhancement of gene expression is typically greatest when placed near the 5' end of the transcription unit.
  • the term "functional fragment” refers to any nucleic acid or protein which comprises merely a part of the fulllength nucleic acid or fulllength protein, respectively, but still provides the same function, e.g., fungal resistance, when expressed or repressed in a plant, respective- ly.
  • the fragment comprises at least 50%, at least 60%, at least 70%, at least 80 %, at least 90 % at least 95%, at least 98 %, at least 99% of the original sequence.
  • the functional fragment comprises contiguous nucleic acids or amino acids as in the original nucleic acid or original protein, respectively.
  • the fragment of any of the HCP5 nucleic acids has an identity as defined above over a length of at least 20%, at least 30%, at least 50%, at least 75%, at least 90% of the nucleotides of the respective HCP5 nucleic acid.
  • splice variant encompasses variants of a nucleic acid sequence in which selected introns and/or exons or parts thereof have been excised, replaced, displaced or added, or in which introns have been shortened or lengthened.
  • a splice variant can have one or more or even all introns removed or added or partially removed or partially added.
  • a cDNA is considered as a splice variant of the respective intron-containing genomic sequence and vice versa.
  • Such splice variants may be found in nature or may be manmade. Methods for predicting and isolating such splice variants are well known in the art (see for example Foissac and Schiex (2005) BMC Bioinfor- matics 6: 25).
  • similar functional activity means that any homologue and/or fragment provide fungal resistance when expressed in a plant.
  • similar functional activity means at least 50%, at least 60%, at least 70%, at least 80 %, at least 90 %, at least 95%, at least 98 %, at least 99% or 100% or higher fungal resistance compared with functional activity provided by the exogenous expression of the HCP5 nucleotide sequence as defined by SEQ ID NO: 1 or the HCP5 protein sequence as defined by SEQ ID NO: 3.
  • the term "increased activity” or “enhanced activity” as used herein means any protein hav- ing increased activity and which provides an increased fungal resistance compared with the wildtype plant merely expressing the respective endogenous HCP5 nucleic acid. As far as overexpression is concerned, for the purposes of this invention, the original wild-type expression level might also be zero (absence of expression).
  • the term "operatively linked” is intended to mean that the nucleic acid to be expressed is linked to the regulatory sequence, including promoters, terminators, enhancers and/or other expression control elements (e.g., polyadenylation signals), in a manner which allows for expression of the nucleic acid (e.g., in a host plant cell when the vector is introduced into the host plant cell).
  • regulatory sequences are described, for example, in Goeddel, Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, CA (1990) and Gruber and Crosby, in: Methods in Plant Molecular Biology and Biotechnology, Eds.
  • Regulatory sequences include those that direct constitutive expression of a nucleotide sequence in many types of host cells and those that direct expression of the nucleotide sequence only in certain host cells or under certain conditions. It will be appreciated by those skilled in the art that the design of the vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of nucleic acid desired, and the like.
  • introduction or “transformation” as referred to herein encompass the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer.
  • Plant tissue capable of subsequent clonal propagation may be transformed with a vector construct of the present invention and a whole plant regenerated there from.
  • the particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed.
  • tissue targets include leaf disks, pollen, embryos, cotyledons, hy- pocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meri- stem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon me- ristem and hypocotyl meristem).
  • the polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alterna- tively, it may be integrated into the host genome.
  • the host genome includes the nucleic acid contained in the nucleus as well as the nucleic acid contained in the plastids, e.g., chloroplasts, and / or mitochondria.
  • the resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.
  • terminal encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3' processing and polyadenylation of a primary transcript and termination of transcription.
  • the terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.
  • the terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.
  • the HCP5 nucleic acid to be overexpressed in order to achieve increased resistance to fungal pathogens is preferably a nucleic acid coding for an HCP5 protein, and is preferably as defined by SEQ ID NO: 10, 1 , 2, 4, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, or a fragment, homolog, derivative, orthologue or paralogue thereof, or a splice variant thereof.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10, 1 , 2, 4, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, or is a functional fragment thereof, or a splice variant thereof. Most preferred is at least 95 % identity, more preferred is at least 90% identity, at least 98% or at least 99% identity with SEQ ID NO: 10, 1 , 2, 4, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34.
  • the HCP5 nucleic acid to be overexpressed in order to achieve increased re- sistance to fungal pathogens e.g., of the family Phakopsoraceae, for example soybean rust
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 4 or is a functional fragment thereof, or a splice variant thereof. Most preferred is at least 90% identity, at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 4.
  • the HCP5 nucleic acid to be overexpressed in order to achieve increased resistance to fungal pathogens is preferably a nucleic acid coding for an HCP5 protein, and is preferably as defined by SEQ ID NO: 1 , or a fragment, homolog, derivative, orthologue or paralogue thereof, or a splice variant thereof.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1 or is a functional fragment thereof, or a splice variant thereof. Most preferred is at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 1.
  • the HCP5 nucleic acid to be overexpressed in order to achieve increased resistance to fungal pathogens is preferably a nucleic acid coding for an HCP5 protein, and is preferably as defined by SEQ ID NO: 10, or a fragment, homolog, derivative, orthologue or paralogue thereof, or a splice variant thereof.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10 or is a functional fragment thereof, or a splice variant thereof. Most preferred is at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 10.
  • the HCP5 nucleic acid to be overexpressed in order to achieve increased resistance to fungal pathogens is preferably a nucleic acid coding for an HCP5 protein, and is preferably as defined by SEQ ID NO: 5, or a fragment, homolog, derivative, orthologue or paralogue thereof, or a splice variant thereof.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 5 or is a functional fragment thereof, or a splice variant thereof. Most preferred is at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 5.
  • SEQ ID NO: 10 corresponds to SEQ ID NO: 1 , wherein in SEQ ID NO: 10 certain recognition sites for restriction endonucleases have been removed.
  • the HCP5 nucleic acid is an isolated nucleic acid molecule consisting of or comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 11 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28,
  • nucleic acid encoding a HCP5 protein comprising an amino acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 12, 3, 21
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) to (iii) above, but differing from the HCP5 nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1. Most preferred is at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 1.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 2. Most preferred is at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 2.
  • the nucleic acid coding for an HCP5 protein of the present invention has at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10. Most preferred is at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 10.
  • the HCP5 nucleic acid is an isolated nucleic acid molecule consisting of or comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence rep- resented by SEQ ID NO: 1 , or a functional fragment, derivative, ortho
  • nucleic acid encoding a HCP5 protein having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 3, or a functional fragment, derivative, ortho
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • the HCP5 nucleic acid is an isolated nucleic acid molecule consisting of or comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 10, or a functional fragment, derivative, orthologue, or pa- ra
  • nucleic acid encoding a HCP5 protein having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 3, or a functional fragment, derivative, ortho
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) to (iii) above, but differing from the HCP5 nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • Percentages of identity of a nucleic acid are indicated with reference to the entire nucleotide region given in a sequence specifically disclosed herein.
  • the portion of the HCP5 nucleic acid is about 1000-1200, about 1200-1400, about 1400-1600, about 1600-1800, about 1800-2000, about 2000-2200, about 2200-2400, about 2400-2600, about 2600-2800, about 2800-3000, or about 3000-3123 nucleotides, preferably consecutive nucleotides, preferably counted from the 5' or 3' end of the nucleic acid, in length, of the nucleic acid sequences given in SEQ ID NO: 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34.
  • the HCP5 nucleic acid comprises at least about 1400, at least about 1600, at least about 1800, at least about 2000, at least about 2200, at least about 2400, at least about 2600, at least about 2800, at least about 3000, or at least about 3100 nucleotides, preferably continuous nucleotides, preferably counted from the 5' or 3' end of the nucleic acid or up to the full length of the nucleic acid sequence set out in SEQ ID NO: 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34.
  • the HCP5 nucleic acid comprises at least about 1600, at least about 1800, at least about 2000, at least about 2100, at least about 2200, at least about 2300, or at least about 2400 nucleotides, preferably continuous nucleotides, preferably counted from the 5' or 3' end of the nucleic acid or up to the full length of the nucleic acid sequence set out in SEQ ID NO: 1.
  • the portion of the HCP5 nucleic acid is about 1000-1100, about 1 100-1200, about 1200-1300, about 1300-1400, about 1400-1500, about 1500-1600, about 1600-1700, about 1700-1800, about 1800-1900, about 1900-2000, about 2000-2100, about 2100-2200, about 2200-2300, or about 2300-2403 nucleotides, preferably consecutive nucleotides, preferably counted from the 5' or 3' end of the nucleic acid, in length, of the nucleic acid sequences given in SEQ ID NO: 1.
  • the HCP5 nucleic acid comprises at least about 1600, at least about 1800, at least about 2000, at least about 2100, at least about 2200, at least about 2300, or at least about 2400 nucleotides, preferably continuous nucleotides, preferably counted from the 5' or 3' end of the nucleic acid or up to the full length of the nucleic acid sequence set out in SEQ ID NO: 10 or 13-19.
  • the portion of the HCP5 nucleic acid is about 1000-1 100, about 1 100-1200, about 1200-1300, about 1300-1400, about 1400-1500, about 1500-1600, about 1600-1700, about 1700-1800, about 1800-1900, about 1900-2000, about 2000-2100, about 2100-2200, about 2200-2300, or about 2300-2403 nucleotides, preferably consecutive nucleotides, preferably counted from the 5' or 3' end of the nucleic acid, in length, of the nucleic acid sequences given in SEQ ID NO: 10 or 13-19.
  • the HCP5 nucleic acid comprises at least about 500, at least about 600, at least about 700, at least about 750, or at least about 800 nucleotides, preferably continuous nucleotides, preferably counted from the 5' or 3' end of the nucleic acid or up to the full length of the nucleic acid sequence set out in SEQ ID NO: 1 1.
  • the portion of the HCP5 nucleic acid is about 500-600, about 600-700, about 700-725, about 725-750, about 750-775, about 775-800, or about 800-829 nucleotides, preferably consecutive nucleotides, preferably counted from the 5' or 3' end of the nucleic acid, in length, of the nucleic acid sequences given in SEQ ID NO: 1 1.
  • the HCP5 nucleic acid is a HCP5 nucleic acid splice variant.
  • Preferred splice variants are splice variants of a nucleic acid represented by SEQ ID NO: 4.
  • Preferred HCP5 nucleic acids being a splice variant of SEQ ID NO: 4 are shown in Figure 7.
  • the HCP5 nucleic acid is an isolated nucleic acid molecule comprising a splice variant of SEQ ID NO: 4, wherein the splice variant is selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 10, 1 , or 2, or a functional fragment, derivative, orthologue, or
  • nucleic acid encoding a HCP5 protein having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 3, or a functional fragment, deriva-
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; prefera- bly encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • a nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) to (iii) above, but differing from the HCP5 nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • Preferred splice variants of SEQ ID NO: 4 consist of or comprise anyone of the nucleotide sequences shown in SEQ ID NO: 10, 1 , or 2. Most preferred is the HCP5 nucleic acid splice variant as shown in SEQ ID NO: 2.
  • the HCP5 nucleic acid is an isolated nucleic acid molecule comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence rep- resented by SEQ ID NO: 4, or a splice variant thereof;
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID No: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) or (ii) above, but differing from the HCP5 nucleic acids of (i) or (ii) above due to the degeneracy of the genetic code;
  • splice variant thereof is selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 10, 1 , or 2, or a functional fragment, derivative, orthologue, or
  • nucleic acid encoding a HCP5 protein having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 3, or a functional fragment, derivative, ortho
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) to (iii) above, but differing from the HCP5 nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the HCP5 nucleic acid is an isolated nucleic acid molecule comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 4, or a splice variant thereof;
  • splice variant thereof is selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 10, 1 , or 2; preferably SEQ ID NO: 10.
  • the HCP5 nucleic acid comprises a nucleic acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 1 1 , or
  • the HCP5 nucleic acid comprises a nucleic acid sequence hav- ing in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 10,
  • the HCP5 nucleic acid is a splice variant comprising a nucleic acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by S
  • the HCP5 nucleic acid comprises an exon sequence comprising a nucleic acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 1
  • the HCP5 nucleic acid comprises a nucleic acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 10, 1 , 2,
  • the HCP5 nucleic acid encodes a HCP5 protein comprising an amino acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% se- quence identity to the amino acid sequence represented by SEQ ID
  • the HCP5 nucleic acid encodes a HCP5 protein having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 3, or a functional fragment,
  • HCP5 nucleic acids described herein are useful in the constructs, methods, plants, harvestable parts and products of the invention.
  • HCP5 proteins are useful in the constructs, methods, plants, harvestable parts and products of the invention.
  • the HCP5 protein is preferably defined by SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or a fragment, homolog, derivative, orthologue or paralogue thereof.
  • the HCP5 protein of the present invention is encoded by a nucleic acid, which has at least 60% identi- ty, preferably at least 70% sequence identity, at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35 or a functional fragment thereof.
  • the HCP5 protein of the present invention has at least 60%, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% se- quence identity, or even 100% sequence identity with SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or is a functional fragment thereof, an orthologue or a paralogue thereof. Most preferred is at least 90 % identity, at least 95 % identity, more preferred is at least 98% or at least 99% identity with SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35.
  • the HCP5 protein of the present invention comprises an amino acid sequence that has at least 60%, preferably at least 70% sequence identity, at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12.
  • the HCP5 protein of the present invention has at least 60%, preferably at least 70% sequence identity, at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, wherein the HCP5 protein comprises an amino acid sequence having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12; or is a functional fragment thereof, an orthologue or a paralogue thereof.
  • the HCP5 protein is a protein consisting of or comprising an amino acid sequence selected from the group consisting of:
  • an amino acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or a functional fragment
  • an amino acid sequence encoded by a nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least
  • the HCP5 protein is a protein comprising an amino acid sequence selected from the group consisting of:
  • an amino acid sequence having in increasing order of preference at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by
  • HCP5 protein has essentially the same biological activity as an HCP5 protein encoded by SEQ ID NO: 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34; preferably the HCP5 protein confers en- hanced fungal resistance relative to control plants; or
  • nucleic acid having in increasing order of preference at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, or a functional fragment, derivative, orthologue, or paralogue thereof, or a splice variant thereof; preferably the HCP5 protein confers enhanced fungal resistance relative to control plants.
  • a preferred derivative of a HCP5 protein is a HCP5 protein consisting of or comprising an amino acid sequence selected from the group consisting of:
  • amino acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to the amino acid sequence represented by SEQ ID NO: 12 or 3,
  • the non-identical amino acid residues are conservative amino acid substitutions, preferably as shown in Table 1 , of the corresponding amino acid residue of SEQ ID NO: 12 or 3; preferably the HCP5 protein has essentially the same biological activity as SEQ ID NO: 3 or as a HCP5 protein encoded by SEQ ID NO: 10, 1 , 2 or 4; preferably the HCP5 protein confers enhanced fungal resistance relative to control plants.
  • the HCP5 protein consists of or comprises an amino acid sequence represented by SEQ ID NO: 3 with one or more conservative amino acid substitutions, preferably as shown in Table 1 , of the corresponding amino acid residues of SEQ ID NO: 3.
  • the HCP5 protein consists of or comprises an amino acid sequence having at least 80 %, at least 85%, at least 90%, at least 95%, at least 98% or at least 99% sequence identity with an amino acid sequence as represented by SEQ ID NO: 12 or 3, wherein at least 1 , at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 1 1 , at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, at least 21 , at least 22, at least 23, at least 24, at least 25, at least 26, at least 27, at least 28, at least 29, or at least 30 of the non- identical amino acid residues, or wherein 1 -10, 10-20, 20-30, 40-50, 50-60, 60-70, 70-80, 80-90 or 90-100 or even all of the non-identical amino acid residues are conservative amino acid substitutions, preferably as shown in Table 1 , of the corresponding amino acid residue of SEQ ID NO: 12, 3, 21
  • the HCP5 protein comprises at least about 300, at least about 400, at least about 450, at least about 500, at least about 520, at least about 540, at least about 560, at least about 580, at least about 590, at least about 600, at least about 610, or at least about 620 amino acid residues, preferably continuous amino acid residues, preferably counted from the N-terminus or the C-terminus of the amino acid sequence, or up to the full length of the amino acid sequence set out in SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35.
  • the HCP5 polypeptide comprises about 300-400, about 400-500, about 500- 520, about 520-540, about 540-560, about 560-580, about 580-590, about 590-600, about 600-610, about 610-623 amino acids, preferably consecutive amino acids, preferably counted from the N-terminus or C-terminus of the amino acid sequence, or up to the full length of any of the amino acid sequences encoded by the nucleic acid sequences set out in SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35.
  • the HCP5 protein comprises at least about 100, at least about 125, at least about 150, at least about 175, at least about 200, at least about 225, at least about 250, or at least about 275 amino acid residues, preferably continuous amino acid residues, preferably counted from the N-terminus or the C-terminus of the amino acid sequence, or up to the full length of the amino acid sequence set out in SEQ ID NO: 12.
  • the HCP5 polypeptide comprises about 100-125, about 125-150, about 150- 175, about 175-200, about 200-225, about 225-250, or about 250-275 amino acids, preferably consecutive amino acids, preferably counted from the N-terminus or C-terminus of the amino acid sequence, or up to the full length of any of the amino acid sequences encoded by the nucleic acid sequences set out in SEQ ID NO: 12.
  • HCP5 proteins described herein are useful in the constructs, methods, plants, harvest- able parts and products of the invention.
  • One embodiment of the invention is a method for increasing fungal resistance, preferably resistance to Phakopsoraceae, for example soy bean rust, in a plant, plant part, or plant cell by increasing the expression of an HCP5 protein or a functional fragment, orthologue, pa- ralogue or homologue thereof in comparison to wild-type plants, wild-type plant parts or wild-type plant cells.
  • the present invention also provides a method for increasing resistance to fungal patho- gens, in particular a heminecrotrophic pathogen, in particular to rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably fungal pathogens of the family
  • Phakopsoraceae preferably against fungal pathogens of the genus Phakopsora, most pref- erably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soy bean rust in plants or plant cells, wherein in comparison to wild type plants, wild type plant parts, or wild type plant cells an HCP5 protein is overexpressed.
  • the present invention further provides a method for increasing resistance to fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and
  • Phakopsora meibomiae also known as soy bean rust in plants or plant cells by overexpres- sion of an HCP5 protein.
  • the protein amount and / or function of the HCP5 protein in the plant is increased by at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or at least 95% or more in comparison to a wild type plant that is not transformed with the HCP5 nucleic acid.
  • the HCP5 protein is encoded by a nucleic acid comprising
  • an exogenous nucleic acid having at least 60%, preferably at least 70%, for example at least 75%, more preferably at least 80%, for example at least 85%, even more preferably at least 90%, for example at least 95% or at least 96% or at least 97% or at least 98% most preferably 99% identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, a functional fragment thereof, or an orthologue or a pa- ralogue thereof, or a splice variant thereof; or by
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60% identity, preferably at least 70%, for example at least 75%, more preferably at least 80%, for example at least 85%, even more preferably at least 90%, for example at least 95% or at least 96% or at least 97% or at least 98% most preferably 99% homology with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, a functional fragment thereof, an orthologue or a paralogue thereof, preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • an exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35; preferably the encoded protein confers enhanced fungal resistance relative to control plants; or by
  • the HCP5 protein comprises an amino acid sequence
  • an exogenous nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, or a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60%, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • an exogenous nucleic acid having at least 60% identity, preferably at least 70% se- quence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1 or a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • an exogenous nucleic acid encoding a protein having at least 60%, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • an exogenous nucleic acid having at least 60% identity, preferably at least 70% se- quence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10 or a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • an exogenous nucleic acid encoding a protein having at least 60%, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • the method comprises the steps of
  • nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, or a functional fragment thereof, or an orthologue or a paralogue thereof, or a splice variant thereof;
  • nucleic acid coding for a protein comprising an amino acid sequence having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 polypeptide as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • nucleic acid (c) expressing said nucleic acid, optionally wherein the nucleic acid which codes for an HCP5 protein is expressed in an amount and for a period sufficient to generate or to increase soybean rust resistance in said plant.
  • the method comprises the steps of
  • nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1 , or a functional fragment thereof, or an orthologue or a paralogue thereof, or a splice variant thereof;
  • nucleic acid coding for a protein having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 polypeptide as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • nucleic acid (c) expressing said nucleic acid, optionally wherein the nucleic acid which codes for an HCP5 protein is expressed in an amount and for a period sufficient to generate or to increase soybean rust resistance in said plant.
  • the method comprises the steps of
  • nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10, or a functional fragment thereof, or an orthologue or a paralogue thereof, or a splice variant thereof;
  • nucleic acid coding for a protein having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers en- hanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 polypeptide as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • nucleic acid (c) expressing said nucleic acid, optionally wherein the nucleic acid which codes for an HCP5 protein is expressed in an amount and for a period sufficient to generate or to increase soybean rust resistance in said plant.
  • the method for increasing fungal resistance preferably resistance to
  • Phakopsoraceae for example soy bean rust, in a plant, plant part, or plant cell further com- prises the step of selecting a transgenic plant expressing
  • an exogenous nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10, 1 , 2, or 4, or a functional fragment thereof, or an orthologue or a paralogue thereof, or a splice var- iant thereof;
  • an exogenous nucleic acid coding for a protein having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • an exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • an exogenous nucleic acid encoding the same HCP5 polypeptide as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • a preferred embodiment is a method for increasing resistance to soy bean rust in a soy bean plant, soy bean plant part, or soy bean plant cell, by increasing the expression of an HCP5 protein, wherein the HCP5 protein is encoded by a nucleic acid comprising
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12 or 3; preferably the en- coded protein confers enhanced fungal resistance relative to control plants;
  • an exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • HCP5 protein is achieved by transforming the soy bean plant, plant part or plant cell with a nucleic acid comprising the nucleic acid set out under item (i) or (ii) or (iii) or (iv).
  • a preferred embodiment is a method for increasing resistance to soy bean rust in a soy bean plant, soy bean plant part, or soy bean plant cell, by increasing the expression of an HCP5 protein, wherein the HCP5 protein is encoded by a nucleic acid comprising
  • an exogenous nucleic acid having at least 80%, at least 90%, at least 95 %, at least
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29,
  • the encoded protein confers enhanced fungal resistance relative to control plants;
  • the fungal pathogens or fungus-like pathogens can belong to the group comprising Plasmodiophoramycota, Oomycota, Ascomycota, Chytridio- mycetes, Zygomycetes, Basidiomycota or Deuteromycetes (Fungi imperfecti).
  • Pathogens which may be mentioned by way of example, but not by limitation, are those detailed in Tables 2 and 3, and the diseases which are associated with them.
  • Angiopsora zeae Table 3 Diseases caused by necrotrophic and/or hemibiotrophic fungi and Oomycetes
  • Anthrocnose leaf blight Colletotrichum graminicola (teleomorph: Glo- merella graminicola Politis); Glomerella tucu- Anthracnose stalk rot manensis (anamorph: Glomerella falcatum Went)
  • Curvularia leaf spot Curvularia clavata, C. eragrostidis, C. maculans
  • Green ear downy mildew (gramini- Sclerospora graminicola
  • Exserohilum prolatum Drechslera prolata (teleomorph: Setosphaeria prolata)
  • Leptosphaeria maydis, Leptothyrium zeae, Ophi- osphaerella herpotricha, (anamorph: Scolecospor- iella sp.),
  • Phaeosphaeria leaf spot Phaeosphaeria maydis Sphaerulina maydis
  • thosporium leaf disease, ear and xserohilum rostratum Helminthosporium rostrastalk rot) tum
  • phaseolina Penicillium spp., Phomopsis sp., Pythium spp., Rhizoctonia solani, R. zeae, Sclerotium rolfsii, Spicaria sp.
  • Plasmodiophoromycota such as Plasmodiophora brassicae (clubroot of crucifers), Spongospora subterranea, Polymyxa graminis,
  • Oomycota such as Bremia lactucae (downy mildew of lettuce), Peronospora (downy mildew) in snapdragon (P. antirrhini), onion (P. destructor), spinach (P. effusa), soybean (P. manchurica), tobacco ("blue mold”; P. tabacina) alfalfa and clover (P. trifoli- um), Pseudoperonospora humuli (downy mildew of hops), Plasmopara (downy mildew in grapevines) (P. viticola) and sunflower (P.
  • Ascomycota such as Microdochium nivale (snow mold of rye and wheat), Fusarium, Fusarium graminearum, Fusarium culmorum (partial ear sterility mainly in wheat), Fusarium oxysporum (Fusarium wilt of tomato), Blumeria graminis (powdery mildew of barley (f.sp. hordei) and wheat (f.sp.
  • Basidiomycetes such as Typhula incarnata (typhula blight on barley, rye, wheat), Usti- lago maydis (blister smut on maize), Ustilago nuda (loose smut on barley), Ustilago tritici (loose smut on wheat, spelt), Ustilago avenae (loose smut on oats), Rhizoctonia solani (rhizoctonia root rot of potato), Sphacelotheca spp. (head smut of sorghum), Melampsora lini (rust of flax), Puccinia graminis (stem rust of wheat, barley, rye, oats),
  • Puccinia recondita (leaf rust on wheat), Puccinia dispersa (brown rust on rye), Puccinia hordei (leaf rust of barley), Puccinia coronata (crown rust of oats), Puccinia strii- formis (yellow rust of wheat, barley, rye and a large number of grasses), Uromyces appendiculatus (brown rust of bean), Sclerotium rolfsii (root and stem rots of many plants).
  • Deuteromycetes such as Septoria (Stagonospora) nodorum (glume blotch) of wheat (Septoria tritici), Pseudocercosporella herpotrichoides (eyespot of wheat, barley, rye), Rynchosporium secalis (leaf spot on rye and barley), Alternaria solani (early blight of potato, tomato), Phoma betae (blackleg on Beta beet), Cerco- spora beticola (leaf spot on Beta beet), Alternaria brassicae (black spot on oilseed rape, cabbage and other crucifers), Verticillium dahliae (verticillium wilt), Colleto- trichum, Colletotrichum lindemuthianum (bean anthracnose), Phoma lingam (blackleg of cabbage and oilseed rape), Botrytis cinerea (grey mold of grapevine, strawberry, tomato
  • biotrophic pathogens e.g., Phakopsora pachyrhizi and/or those pathogens which have essentially a similar infection mechanism as Phakopsora pachyrhizi, as described herein.
  • pathogens from the subclass Pucciniomy- cetes preferably from the order Pucciniales, preferably the group Uredinales (rusts), among which in particular the Melompsoraceae.
  • Phakopsoraceae more preferably Phakopsora.
  • Phakopsora pachyrhizi and/or Phakopsora meibomi- ae are especially preferred.
  • Also preferred rust fungi are selected from the group of Puccinia, Gymnosporangium, Juni- perus, Cronartium, Hemileia, and Uromyces; preferably Puccinia sorghi, Gymnosporangium juniperi-virginianae, Juniperus virginiana, Cronartium ribicola, Hemileia vastatrix, Puccinia graminis, Puccinia coronata, Uromyces phaseoli, Puccinia hemerocallidis, Puccinia persis- tens subsp. Triticina, Puccinia striiformis, Puccinia graminis causes, and / or Uromyces ap- pendeculatus.
  • a recombinant vector construct comprising:
  • nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, or a functional fragment thereof, or an orthologue or a paralogue thereof, or a splice variant thereof;
  • nucleic acid coding for a protein comprising an amino acid sequence having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a comple- mentary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • a transcription termination sequence is a further embodiment of the invention.
  • a recombinant vector construct comprising:
  • nucleic acid coding for a protein comprising an amino acid sequence having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a comple- mentary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • a transcription termination sequence is a further embodiment of the invention.
  • a recombinant vector construct comprising:
  • nucleic acid coding for a protein having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • a transcription termination sequence is a further embodiment of the invention.
  • a recombinant vector construct comprising:
  • nucleic acid coding for a protein having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code
  • a transcription termination sequence is a further embodiment of the invention.
  • Promoters according to the present invention may be constitutive, inducible, in particular pathogen-inducible, developmental stage-preferred, cell type-preferred, tissue-preferred or organ-preferred. Constitutive promoters are active under most conditions. Non-limiting ex- amples of constitutive promoters include the CaMV 19S and 35S promoters (Odell et al., 1985, Nature 313:810-812), the sX CaMV 35S promoter (Kay et al., 1987, Science
  • the Sep1 promoter the rice actin promoter (McElroy et al., 1990, Plant Cell 2:163-171 ), the Arabidopsis actin promoter, the ubiquitin promoter (Christensen et al., 1989, Plant Molec. Biol. 18:675-689); pEmu (Last et al., 1991 , Theor. Appl. Genet. 81 :581 - 588), the figwort mosaic virus 35S promoter, the Smas promoter (Velten et al., 1984, EMBO J.
  • the GRP1 -8 promoter the GRP1 -8 promoter
  • the cinnamyl alcohol dehydrogenase promoter U.S. Patent No. 5,683,439
  • promoters from the T-DNA of Agrobacterium such as man- nopine synthase, nopaline synthase, and octopine synthase
  • ssuRUBISCO small subunit of ribulose biphosphate carboxylase
  • the expression vector of the invention comprises a constitutive promoter, meso- phyll-specific promoter, epidermis-specific promoter, root-specific promoter, a pathogen inducible promoter, or a fungal-inducible promoter.
  • a promoter is inducible, if its activity, measured on the amount of RNA produced under control of the promoter, is at least 30%, at least 40%, at least 50% preferably at least 60%, at least 70%, at least 80%, at least 90% more preferred at least 100%, at least 200%, at least 300% higher in its induced state, than in its un-induced state.
  • a promoter is cell-, tissue- or organ-specific, if its activity , measured on the amount of RNA produced under control of the promoter, is at least 30%, at least 40%, at least 50% preferably at least 60%, at least 70%, at least 80%, at least 90% more preferred at least 100%, at least 200%, at least 300% higher in a particular cell-type, tissue or organ, then in other cell-types or tissues of the same plant, preferably the other cell-types or tissues are cell types or tissues of the same plant organ, e.g. a root.
  • the promoter activity has to be compared to the promoter activity in other plant organs, e.g. leaves, stems, flowers or seeds.
  • the promoter is a constitutive promoter, mesophyll-specific promoter, or epidermis-specific promoter.
  • a promoter from parsley preferably, the parsley ubiquitine promoter.
  • a preferred terminator is the terminator of the cathepsin D inhibitor gene from Solanum tuberosum.
  • the increase in the protein amount and/or activity of the HCP5 protein takes place in a constitutive or tissue-specific manner.
  • an essentially pathogen-induced increase in the protein amount and/or protein activity takes place, for example by recombinant expression of the HCP5 nucleic acid under the control of a fungal-inducable promoter.
  • the expression of the HCP5 nucleic acid takes place on fungal infected sites, where, however, preferably the expression of the HCP5 nucleic acid remains essentially unchanged in tissues not infected by fungus.
  • tissue and organ preferred promoters include those that are preferentially expressed in certain tissues or organs, such as leaves, roots, seeds, or xylem.
  • tissue preferred and organ preferred promoters include, but are not limited to fruit- preferred, ovule-preferred, male tissue-preferred, seed-preferred, integument-preferred, tuber-preferred, stalk-preferred, pericarp-preferred, leaf-preferred, stigma-preferred, pollen- preferred, anther-preferred, a petal -preferred, sepal-preferred, pedicel-preferred, silique- preferred, stem-preferred, root-preferred promoters and/or the like.
  • Seed preferred promoters are preferentially expressed during seed development and/or germination.
  • seed preferred promoters can be embryo-preferred, endosperm preferred and seed coat- preferred. See Thompson et al., 1989, BioEssays 10:108.
  • seed preferred promoters include, but are not limited to cellulose synthase (celA), Cim1 , gamma-zein, globu- lin-1 , maize 19 kD zein (cZ19B1 ) and/or the like.
  • tissue-preferred or organ-preferred promoters include, but are not limited to, the napin-gene promoter from rapeseed (U.S. Patent No. 5,608,152), the USP-promoter from Vicia faba (Baeumlein et al., 1991 , Mol Gen Genet. 225(3):459-67), the oleosin- promoter from Arabidopsis (PCT Application No. WO 98/45461 ), the phaseolin-promoter from Phaseolus vulgaris (U.S. Patent No. 5,504,200), the Bce4-promoter from Brassica (PCT Application No.
  • WO 91/13980 or the legumin B4 promoter (LeB4; Baeumlein et al., 1992, Plant Journal, 2(2):233-9), as well as promoters conferring seed specific expression in monocot plants like maize, barley, wheat, rye, rice, etc.
  • Suitable promoters to note are the Ipt2 or Ipt1 -gene promoter from barley (PCT Application No. WO 95/15389 and PCT Application No. WO 95/23230) or those described in PCT Application No.
  • WO 99/16890 promoters from the barley hordein-gene, rice glutelin gene, rice oryzin gene, rice prolamin gene, wheat gliadin gene, wheat glutelin gene, oat glutelin gene, Sorghum kasirin-gene, and/or rye secalin gene).
  • Promoters useful according to the invention include, but are not limited to, are the major chlorophyll a/b binding protein promoter, histone promoters, the Ap3 promoter, the ⁇ - conglycin promoter, the napin promoter, the soybean lectin promoter, the maize 15kD zein promoter, the 22kD zein promoter, the 27kD zein promoter, the g-zein promoter, the waxy, shrunken 1 , shrunken 2, bronze promoters, the Zm13 promoter (U.S. Patent No.
  • Epidermis-spezific promoters may be selected from the group consisting of:
  • GLP4 acc. AJ310534; Wei Y., Zhang Z., Andersen C.H., Schmelzer E., Gregersen P.L., Collinge D.B., Smedegaard-Petersen V. and Thordal-Christensen H., Plant Molecular Biology 36, 101 (1998),
  • GLP2a acc. AJ237942, Schweizer P., Christoffel A. and Dudler R., Plant J. 20, 541 (1999); Prx7, acc. AJ003141 , Kristensen B.K., Ammitzboll H., Rasmussen S.K. and Nielsen K.A., Molecular Plant Pathology, 2(6), 31 1 (2001);
  • GerA acc. AF250933; Wu S., Druka A., Horvath H., Kleinhofs A., Kannangara G. and von
  • AtProT3 Promoter (Grallath et al., Plant Physiology. 137(1 ), 1 17 (2005));
  • Mesophyll-specific promoters may be selected from the group consisting of:
  • PPCZml PEPC
  • Kausch A.P. Owen T.P.
  • Zachwieja S.J. Flynn A.R. and Sheen J., Plant Mol. Biol. 45, 1 (2001 );
  • TaGF-2.8 acc. M63223; Schweizer P., Christoffel A. and Dudler R., Plant J. 20, 541 (1999); TaFBPase, acc. X53957;
  • HvPRI a acc. X74939; Bryngelsson et al., Mol. Plant Microbe Interact!. 7 (2), 267 (1994);
  • HvPRI b acc. X74940; Bryngelsson et al., Mol. Plant Microbe Interact. 7(2), 267 (1994);
  • HvB1 ,3gluc acc. AF479647;
  • Constitutive promoters may be selected from the group consisting of
  • CaMV 35S promoter Cauliflower Mosaic Virus 35S promoter (Benfey et al. 1989 EMBO J. 8(8): 2195-2202),
  • vector construct is a "plasmid,” which refers to a circular double stranded DNA loop into which additional DNA segments can be ligated.
  • viral vector Another type of vector, wherein additional DNA segments can be ligated into the viral genome.
  • Certain vector constructs are capable of autonomous replication in a host plant cell into which they are introduced. Other vector constructs are integrated into the genome of a host plant cell upon introduction into the host cell, and thereby are replicated along with the host genome. In particular the vector construct is capable of directing the expression of gene to which the vectors is operatively linked.
  • the invention is intended to include such other forms of expression vector constructs, such as viral vectors (e.g., potato virus X, tobacco rattle virus, and/or Gemini virus), which serve equivalent functions.
  • the increase in the protein quantity or function of the HCP5 protein takes place in a constitutive or tissue-specific manner.
  • an essentially pathogen-induced increase in the protein quantity or protein function takes place, for example by exogenous expression of the HCP5 nucleic acid under the control of a fungal-inducible promoter.
  • the expression of the HCP5 nucleic acid takes place on fungal infected sites, where, however, preferably the expression of the HCP5 nucleic acid sequence remains essentially unchanged in tissues not infected by fungus.
  • the protein amount of an HCP5 protein in the plant is increased by at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or at least 95% or more in comparison to a wild type plant that is not transformed with the HCP5 nucleic acid.
  • a preferred embodiment is the use of an expression construct or a vector as described herein for the transformation of a plant, plant part, or plant cell to provide a pathogen resistant plant, plant part, or plant cell.
  • a preferred embodiment is the use of an expres- sion construct or a vector as described herein for increasing pathogen resistance in a plant, plant part, or plant cell compared to a control plant, plant part, or plant cell.
  • transgenic organisms transgenic plants, plant parts, and plant cells
  • a preferred embodiment is a transgenic plant, transgenic plant part, or transgenic plant cell overexpressing an exogenous HCP5 protein.
  • the HCP5 protein overexpressed in the plant, plant part or plant cell is encoded by a nucleic acid comprising
  • an exogenous nucleic acid having at least 60% identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34 or a functional fragment, thereof, an orthologue or a paralogue thereof, or a splice variant thereof; or by
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60% identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal re- sistance relative to control plants; and / or by
  • an exogenous nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the exogenous nucleic acid has at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34; or comprises an exogenous nucleic acid encoding a protein having at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3.
  • a preferred embodiment is a transgenic plant, transgenic plant part, or transgenic plant cell overexpressing an exogenous HCP5 protein.
  • the HCP5 protein overexpressed in the plant, plant part or plant cell is encoded by
  • an exogenous nucleic acid encoding a protein having at least 60% identity with SEQ ID NO: 3, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • an exogenous nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • a preferred embodiment is a transgenic plant, transgenic plant part, or transgenic plant cell overexpressing an exogenous HCP5 protein.
  • the HCP5 protein overexpressed in the plant, plant part or plant cell is encoded by
  • an exogenous nucleic acid encoding a protein having at least 60% identity with SEQ ID NO: 3, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • an exogenous nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the exogenous nucleic acid has at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 1 ; or comprises an exogenous nucleic acid encoding a protein having at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3.
  • the exogenous nucleic acid has at least 80%, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10; or comprises an exogenous nucleic acid encoding a protein having at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3.
  • the transgenic plant, transgenic plant part, or transgenic plant cell according to the present invention has been obtained by transformation with a recombinant vector described herein.
  • Suitable methods for transforming or transfecting host cells including plant cells are well known in the art of plant biotechnology. Any method may be used to transform the recombinant expression vector into plant cells to yield the transgenic plants of the invention.
  • General methods for transforming dicotyledonous plants are disclosed, for example, in U.S. Pat. Nos. 4,940,838; 5,464,763, and the like.
  • Methods for transforming specific dicotyledonous plants, for example, cotton are set forth in U.S. Pat. Nos. 5,004,863; 5,159,135; and 5,846,797. Soy transformation methods are set forth in U.S. Pat. Nos. 4,992,375;
  • Transformation methods may include direct and indirect methods of transformation. Suitable direct methods include polyethylene glycol induced DNA uptake, liposome-mediated transformation (US 4,536,475), biolistic methods using the gene gun (Fromm ME et al.,
  • Transformation can also be carried out by bacterial infection by means of Agrobacterium (for example EP 0 1 16 718), viral infection by means of viral vectors (EP 0 067 553; US 4,407,956; WO 95/34668; WO 93/03161) or by means of pollen (EP 0 270 356; WO
  • Agrobacterium based transformation techniques (especially for dicotyledonous plants) are well known in the art.
  • the Agrobacterium strain e.g., Agrobacterium tumefaciens or Agrobacterium rhizogenes
  • the Agrobacterium strain comprises a plasmid (Ti or Ri plasmid) and a T-DNA element which is transferred to the plant following infection with Agrobacterium.
  • the T-DNA (transferred DNA) is integrated into the genome of the plant cell.
  • the T-DNA may be localized on the Ri- or Ti-plasmid or is separately comprised in a so-called binary vector.
  • Agrobacterium-mediated transformation Methods for the Agrobacterium-mediated transformation are described, for example, in Horsch RB et al. (1985) Science 225:1229.
  • the Agrobacterium-mediated transformation is best suited to dicotyledonous plants but has also been adapted to monocotyledonous plants.
  • the transformation of plants by Agrobacteria is described in, for example, White FF, Vectors for Gene Transfer in Higher Plants, Transgenic Plants, Vol. 1 , Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15 - 38; Jenes B et al. Techniques for Gene Transfer, Transgenic Plants, Vol. 1 , Engineering and Utilization, edit- ed by S.D. Kung and R.
  • Transformation may result in transient or stable transformation and expression.
  • a nucleotide sequence of the present invention can be inserted into any plant and plant cell falling within these broad classes, it is particularly useful in crop plant cells.
  • the genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S.D. Kung and R. Wu, Potrykus or Hofgen and Willmitzer.
  • plant cells or cell groupings may be selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant.
  • the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from un- transformed plants.
  • the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying.
  • a further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants.
  • the transformed plants are screened for the presence of a selectable marker such as the ones described above.
  • the transformed plants may also be directly selected by screening for the presence of the HCP5 nucleic acid.
  • putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation.
  • expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art.
  • the generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques.
  • a first generation (or T1 ) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques.
  • the generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal trans- formants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).
  • the transgenic plant of the present invention or the plant obtained by the method of the present invention has increased resistance against fungal pathogens, preferably rust pathogens (i.e., fungal pathogens of the order Pucciniales), preferably against fungal path- ogens of the family Phakopsoraceae, more preferably against fungal pathogens of the genus Phakopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibo- miae, also known as soybean rust.
  • resistance against Phakopsora pachyrhizi and/or Phakopsora meibomiae is increased.
  • the plant, plant part, or plant cell is a plant or derived from a plant selected from the group consisting of beans, soya, pea, clover, kudzu, lucerne, lentils, lupins, vetches, groundnut, rice, wheat, barley, arabidopsis, lentil, banana, canola, cotton, potatoe, corn, sugar cane, alfalfa, and sugar beet.
  • the plant is selected from the group consisting of beans, soya, pea, clover, kudzu, lucerne, lentils, lupins, vetches, and/or groundnut.
  • the plant is a legume, comprising plants of the genus Phaseolus (comprising French bean, dwarf bean, climbing bean (Phaseolus vulgaris), Lima bean (Phaseolus lunatus L), Tepary bean (Phaseolus acutifolius A. Gray), runner bean (Phaseolus coccineus)); the ge- nus Glycine (comprising Glycine soja, soybeans (Glycine max (L.) Merill)); pea (Pisum)
  • Phaseolus comprising French bean, dwarf bean, climbing bean (Phaseolus vulgaris), Lima bean (Phaseolus lunatus L), Tepary bean (Phaseolus acutifolius A. Gray), runner bean (Phaseolus coccineus)
  • the ge- nus Glycine comprising Glycine soja, soybeans (Glycine max (L.) Merill)
  • pea (Pisum)
  • shelling peas (Pisum sativum L. convar. sativum), also called smooth or round- seeded peas; marrowfat pea (Pisum sativum L. convar. medullare Alef. emend. CO.
  • sugar pea Pisum sativum L. convar. axiphium Alef emend. CO. Lehm
  • snow pea edible-podded pea or mangetout, (Pisum granda sneida L. convar. sneidulo p. shneiderium)
  • peanut Arachis hypogaea
  • clover Trifolium spec
  • medick Medicago
  • kudzu vine Pueraria lobata
  • common lucerne alfalfa
  • sativa L chickpea (Cicer), lentils (Lens) (Lens culinaris Medik.), lupins (Lupinus); vetches (Vicia), field bean, broad bean (Vicia faba), vetchling (Lathyrus) (comprising chickling pea (Lathyrus sativus), heath pea (Lathyrus tuberosus)); genus Vigna (comprising moth bean (Vigna aconitifolia (Jacq.) Marechal), adzuki bean (Vigna angularis (Willd.) Ohwi & H.
  • the plant, plant part, or plant cell is or is derived from soy.
  • the transgenic plant of the present invention or the plant obtained by the method of the present invention is a soybean plant and has increased resistance against fungal pathogens of the order Pucciniales (rust), preferably, of the family Phacopsoraceae, more preferably against fungal pathogens of the genus Phacopsora, most preferably against Phakopsora pachyrhizi and Phakopsora meibomiae, also known as soybean rust.
  • rust Pucciniales
  • rust Pucciniales
  • the family Phacopsoraceae more preferably against fungal pathogens of the genus Phacopsora
  • Phakopsora pachyrhizi and Phakopsora meibomiae also known as soybean rust.
  • resistance against Phakopsora pachyrhizi and/or Phakopsora meibomiae is increased.
  • One embodiment according to the present invention provides a method for producing a transgenic plant, a transgenic plant part, or a transgenic plant cell resistant to a fungal pathogen, preferably of the family Phacosporaceae, for example soybean rust, wherein the recombinant nucleic acid used to generate a transgenic plant comprises a promoter that is functional in the plant cell, operably linked to an HCP5 nucleic acid, which is preferably SEQ ID NO: 1 , and
  • the present invention refers to a method for the production of a transgenic plant, transgenic plant part, or transgenic plant cell having increased fungal resistance, comprising
  • the method for the production of the transgenic plant, transgenic plant part, or transgenic plant cell further comprises the step
  • an exogenous nucleic acid having at least 60% identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60% identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • an exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid mole- cule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by (iv) an exogenous nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • said introducing and expressing does not comprise an essentially biological process.
  • the method for the production of the transgenic plant, transgenic plant part, or transgenic plant cell further comprises the step
  • an exogenous nucleic acid encoding a protein having at least 60% identity with SEQ ID NO: 3, or a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • an exogenous nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the method for the production of the transgenic plant, transgenic plant part, or transgenic plant cell further comprises the step
  • an exogenous nucleic acid encoding a protein having at least 60% identity with SEQ ID NO: 3, or a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • an exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by (iv) an exogenous nucleic acid encoding the same HCP5 protein as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the method for the production of the transgenic plant, transgenic plant part, or transgenic plant cell further comprises the step of selecting a transgenic plant expressing
  • an exogenous nucleic acid having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 10, 1 , 2, 4, 5, 13- 19, 20, 22, 24, 26, 28, 30, 32, or 34, or a functional fragment thereof, or an orthologue or a paralogue thereof, or a splice variant thereof;
  • an exogenous nucleic acid coding for a protein having at least 60% identity, preferably at least 70% sequence identity, at least 80 %, at least 90%, at least 95 %, at least 98%, at least 99% sequence identity, or even 100% sequence identity with SEQ ID NO: 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • an exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • an exogenous nucleic acid encoding the same HCP5 polypeptide as any of the nucleic acids of (i) to (iii) above, but differing from the nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code.
  • the method for the production of the transgenic plant, transgenic plant part, or transgenic plant cell additionally comprises the step of harvesting the seeds of the transgenic plant and planting the seeds and growing the seeds to plants, wherein the grown plant(s) comprises
  • exogenous nucleic acid having at least 60% identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • the exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60% identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • the exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • exogenous nucleic acid having at least 60% identity with SEQ ID NO: 11 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • the exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60% identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • the exogenous nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or
  • the transgenic plants may be selected by known methods as described above (e.g., by screening for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the HCP5 gene or by directly screening for the HCP5 nucleic acid).
  • Harvestable parts of the transgenic plant according to the present invention are part of the invention.
  • the harvestable parts comprise the HCP5 nucleic acid or HCP5 protein.
  • the harvestable parts may be seeds, roots, leaves and/or flowers comprising the HCP5 nucleic acid or HCP5 protein or parts thereof.
  • Preferred parts of soy plants are soy beans comprising the HCP5 nucleic acid or HCP5 protein.
  • a preferred product is meal or oil, preferably, soybean meal or soybean oil.
  • the soybean meal and/or oil comprises the HCP5 nucleic acid or HCP5 protein.
  • the harvestable parts of the transgenic plant according to the present invention or the products derived from a transgenic plant comprise an exogenous nucleic acid molecule consisting of or comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence represented by SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26,
  • nucleic acid encoding a HCP5 protein comprising an amino acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the amino acid sequence represented by SEQ ID NO: 12, 3, 21
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal re- sistance relative to control plants; and
  • nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) to (iii) above, but differing from the HCP5 nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code;
  • the harvestable part of the transgenic plant or the product derived from the transgenic plant comprises a HCP5 protein encoded by any one of the HCP5 nucleic acids of (i) to (iv).
  • the method comprises the steps a) growing the plants of the invention, b) removing the harvestable parts as defined above from the plants and c) producing said product from or by the harvestable parts of the invention.
  • the products obtained by said method comprises an exogenous nucleic acid molecule consisting of or comprising a nucleic acid selected from the group consisting of:
  • nucleic acid having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the nucleic acid sequence rep- resented by SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13
  • nucleic acid encoding a HCP5 protein comprising an amino acid sequence having in increasing order of preference at least 60%, at least 61 %, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71 %, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or
  • the HCP5 protein has essentially the same biological activity as an HCP5 protein encoded by SEQ ID NO: 1 1 , 10, 1 , 2, 4, or 5; preferably the HCP5 protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid molecule which hybridizes with a complementary sequence of anyone of the nucleic acids of (i) or (ii) under high stringency hybridization conditions; preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and
  • nucleic acid encoding the same HCP5 protein as the HCP5 nucleic acids of (i) to (iii) above, but differing from the HCP5 nucleic acids of (i) to (iii) above due to the degeneracy of the genetic code;
  • the product obtained by said method comprises a HCP5 protein encoded by any one of the HCP5 nucleic acids of (i) to (iv).
  • the product may be produced at the site where the plant has been grown, the plants and/or parts thereof may be removed from the site where the plants have been grown to produce the product.
  • the plant is grown, the desired harvestable parts are removed from the plant, if feasible in repeated cycles, and the product made from the harvestable parts of the plant.
  • the step of growing the plant may be performed only once each time the methods of the invention is performed, while allowing repeated times the steps of product production e.g. by repeated removal of harvestable parts of the plants of the invention and if necessary further processing of these parts to arrive at the product. It is also possible that the step of growing the plants of the invention is repeated and plants or harvestable parts are stored until the production of the product is then performed once for the accumulated plants or plant parts.
  • the steps of growing the plants and producing the product may be performed with an overlap in time, even simultaneously to a large extend or sequentially. Generally the plants are grown for some time before the product is produced.
  • the products produced by said methods of the invention are plant products such as, but not limited to, a foodstuff, feedstuff, a food supplement, feed supplement, fiber, cosmetic and/or pharmaceutical.
  • Foodstuffs are regarded as compositions used for nutrition and/or for supplementing nutrition.
  • Animal feedstuffs and animal feed supplements, in particular, are regarded as foodstuffs.
  • inventive methods for the production are used to make agricultural products such as, but not limited to, plant extracts, proteins, amino acids, carbohydrates, fats, oils, polymers, vitamins, and the like.
  • a plant product consists of one or more agricultural products to a large extent.
  • the transgenic plants of the invention may be crossed with similar transgenic plants or with transgenic plants lacking the nucleic acids of the invention or with non-transgenic plants, using known methods of plant breeding, to prepare seeds.
  • the transgenic plant cells or plants of the present invention may comprise, and/or be crossed to another transgenic plant that comprises one or more exogenous nucleic acids, thus creating a "stack" of transgenes in the plant and/or its progeny.
  • the seed is then planted to obtain a crossed fertile transgenic plant comprising the HCP5 nucleic acid.
  • the crossed fertile transgenic plant may have the particular expression cassette inherited through a female parent or through a male parent.
  • the second plant may be an inbred plant.
  • the crossed fertile transgenic may be a hybrid.
  • seeds of any of these crossed fertile transgenic plants can be harvested from fertile transgenic plants and be used to grow progeny generations of transformed plants of this invention including hybrid plant lines comprising the exogenous nucleic acid.
  • one embodiment of the present invention is a method for breeding a fungal resistant plant comprising the steps of
  • an exogenous nucleic acid having at least 60% identity with SEQ ID NO: 1 1 , 10, 1 , 2, 4, 5, 13-19, 20, 22, 24, 26, 28, 30, 32, or 34, a functional fragment thereof, an orthologue or a paralogue thereof, or a splice variant thereof;
  • an exogenous nucleic acid encoding a protein comprising an amino acid sequence having at least 60% identity with SEQ ID NO: 12, 3, 21 , 23, 25, 27, 29, 31 , 33, or 35, or a functional fragment thereof, an orthologue or a paralogue thereof; preferably the encoded protein confers enhanced fungal resistance relative to control plants;
  • nucleic acid capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to (i) or (ii); preferably encoding a HCP5 protein; preferably wherein the nucleic acid molecule codes for a polypeptide which has essentially identical properties to the polypeptide described in SEQ ID NO: 12 or 3; preferably the encoded protein confers enhanced fungal resistance relative to control plants; and / or by
  • Another preferred embodiment is a method for plant improvement comprising
  • step (c) obtaining seed from at least one plant generated from the one plant cell of (b) or the plant of the cross of step (b);
  • transgenic plants may be selected by known methods as described above (e.g., by screening for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the HCP5 gene or screening for the HCP5 nucleic acid itself).
  • the introduced HCP5 nucleic acid may be maintained in the plant cell stably if it is incorporated into a non-chromosomal autonomous replicon or integrated into the plant chromosomes.
  • the exogenous HCP5 nucleic acid preferably resides in a plant expression cassette.
  • a plant expression cassette preferably contains regulatory sequences capable of driving gene expression in plant cells that are functional linked so that each sequence can fulfill its function, for example, termination of transcription by polyadenylation signals.
  • Preferred polyadenylation signals are those originating from Agrobacterium tumefaciens t-DNA such as the gene 3 known as octopine synthase of the Ti-plasmid pTiACH5 (Gielen et al., 1984, EMBO J. 3:835) or functional equivalents thereof, but also all other terminators func- tionally active in plants are suitable.
  • a plant expression cassette preferably contains other functional linked sequences like translational enhancers such as the overdrive-sequence containing the 5'- untranslated leader sequence from tobacco mosaic virus increasing the polypeptide per RNA ratio (Gallie et al., 1987, Nucl.
  • plant ex-pression vectors include those detailed in: Becker, D. et al., 1992, New plant binary vectors with selectable markers located proximal to the left border, Plant Mol. Biol. 20:1 195-1 197; Bevan, M.W., 1984, Binary Agrobacterium vectors for plant transformation, Nucl. Acid. Res. 12:871 1 -8721 ; and Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, Vol. 1 , Engineering and Utilization, eds.: Kung and R. Wu, Academic Press, 1993, S. 15-38.
  • Example 1 General methods
  • oligonucleotides can be affected, for example, in the known fashion using the phosphoamidite method (Voet, Voet, 2nd Edition, Wiley Press New York, pages 896-897).
  • the cloning steps carried out for the purposes of the present invention such as, for example, restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking DNA fragments, transformation of E. coli cells, bacterial cultures, phage multiplication and sequence analysis of recombinant DNA, are carried out as described by Sambrook et al. Cold Spring Harbor Laboratory Press (1989), ISBN 0-87969-309-6.
  • the sequencing of recombi- nant DNA molecules is carried out with an MWG-Licor laser fluorescence DNA sequencer following the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74, 5463 (1977)).
  • Example 2 Cloning of overexpression vector constructs
  • the cDNA was produced from Arabidopsis thaliana (ecotype Col-0) RNA by using the Superscript II cDNA synthesis kit (Invitrogen). All steps of cDNA preparation and purification were performed according as described in the manual.
  • the HCP5 sequence from 5 " UTR to 3 " UTR was spe- cifically amplified from the cDNA by PCR as described in the protocol of the Phusion hot- start, Pfu Ultra, Pfu Turbo or Herculase DNA polymerase (Stratagene).
  • composition for the protocol of the Pfu Ultra, Pfu Turbo or Herculase DNA polymerase was as follows: 1 x PCR buffer, 0.2 mM of each dNTP, 100 ng cDNA of Arabidopsis thaliana (var Columbia-0) , 50 pmol forward primer, 50 pmol reverse primer, 1 u Phusion hot-start, Pfu Ultra, Pfu Turbo or Herculase DNA polymerase.
  • the amplification cycles were as follows:
  • the primers (as shown in SEQ ID 6 and 7) were designed in a way that the specifically bind to sequences in the 5 ' and 3 ' UTR upstream of the start ATG an downstream of the stop codon of the HCP5 coding sequence.
  • the HCP5 full-length sequence (SEQ ID NO: 1 ) was specifically amplified from the eluted PCR fragement (see above) by PCR as described in the protocol of the Phusion hot-start, Pfu Ultra, Pfu Turbo or Herculase DNA polymerase (Stratagene).
  • composition for the protocol of the Pfu Ultra, Pfu Turbo or Herculase DNA polymerase was as follows: 1x PCR buffer, 0.2 mM of each dNTP, 10-50 ng template DNA derived from the previous PCR of, 50 pmol forward primer, 50 pmol reverse primer, 1 u Phusion hot- start, Pfu Ultra, Pfu Turbo or Herculase DNA polymerase.
  • the amplification cycles were as follows:
  • the primers (as shown in SEQ ID NO: 8 and SEQ ID NO: 9) were designed in a way that an Xmal restriction site is located in front of the start-ATG and a Sacll restriction site downstream of the stop-codon.
  • the amplified fragments were digested using the restriction enzymes Xmal and Sacll (NEB Biolabs) and ligated in a Xmal / Sacll digested Gateway pENTRY-B vector (Invitrogen, Life Technologies, Carlsbad, California, USA) in a way that the full-length HCP5 fragment is located in sense direction between the attL1 and attL2 recombination sites.
  • a triple LR reaction (Gateway system, Invitrogen, Life Technologies, Carlsbad, California, USA) was performed according to manufac- turer's protocol by using a pENTRY-A vector containing a parsley ubiquitine promoter, the HCP5 full-length gene in a pENTRY-B vector and a pENTRY-C vector containing the terminator of the cathepsin D inhibitor gene from Solanum tuberosum.
  • a binary pDEST vector which is composed of: (1 ) a Spectinomycin/Streptomycin re- sistance cassette for bacterial selection, (2) a pVS1 origin for replication in Agrobacteria, (3) a pBR322 origin of replication for stable maintenance in E. coli, and (4) between the right and left border an AHAS selection under control of a pcUbi-promoter (see Figure 2).
  • the recombination reaction was transformed into E. coli (DH5alpha), mini-prepped and screened by specific restriction digestions. A positive clone from each vector construct was sequenced and submitted soy transformation.
  • the expression vector constructs (see example 2) were transformed into soy.
  • a variety of soybean cultivar (including Jack, Williams 82, Jake, Stoddard and Resnik) is appro- priate for soy transformation. Soy seeds were sterilized in a chamber with a chlorine gas produced by adding 3.5 ml 12N HCI drop wise into 100 ml bleach (5.25% sodium hypochlorite) in a desiccator with a tightly fitting lid. After 24 to 48 hours in the chamber, seeds were removed and approximately 18 to 20 seeds were plated on solid GM medium with or without 5 ⁇ 6-benzyl-aminopurine (BAP) in 100 mm Petri dishes. Seedlings without BAP are more elongated and roots develop, especially secondary and lateral root formation. BAP strengthens the seedling by forming a shorter and stockier seedling.
  • BAP 6-benzyl-aminopurine
  • the hypocotyl and one and a half or part of both cotyledons were removed from each seedling.
  • the seedlings were then placed on propagation media for 2 to 4 weeks.
  • the seedlings produce several branched shoots to obtain explants from.
  • the majority of the explants originated from the plantlet growing from the apical bud. These explants were preferably used as target tissue.
  • Agrobacterium cultures were prepared by streaking Agrobacterium (e.g., A. tumefaciens or A. rhizogenes) carrying the desired binary vector (e.g. H. Klee. R. Horsch and S. Rogers 1987 Agrobacterium-Mediated Plant Transformation and its further Applications to Plant Biology; Annual Review of Plant Physiology Vol. 38: 467-486) onto solid YEP growth medium (YEP media: 10 g yeast extract, 10 g Bacto Peptone, 5 g NaCI, Adjust pH to 7.0, and bring final volume to 1 liter with H20, for YEP agar plates add 20 g Agar, autoclave) and incubating at 25 °C until colonies appeared (about 2 days).
  • Agrobacterium e.g., A. tumefaciens or A. rhizogenes
  • the desired binary vector e.g. H. Klee. R. Horsch and S. Rogers 1987 Agrobacterium-Mediated Plant Transformation and
  • Soyepicotyl segments prepared from 4 to 8 d old seedlings were used as explants for regeneration and transformation. Seeds of soya cv. L00106CN, 93-41 131 and Jack were germinated in 1/10 MS salts or a similar composition medium with or without cytokinins for 4 to 8 d. Epicotyl explants were prepared by removing the cotyledonary node and stem node from the stem section. The epicotyl was cut into 2 to 5 segments. Especially preferred are segments attached to the primary or higher node comprising axillary meristematic tissue.
  • the explants were used for Agrobacterium infection.
  • Agrobacterium AGL1 harboring a plasmid with the gene of interest (GOI) and the AHAS, bar or dsdA selectable marker gene was cultured in LB medium with appropriate antibiotics overnight, harvested and resus- pended in a inoculation medium with acetosyringone.
  • Freshly prepared epicotyl segments were soaked in the Agrobacterium suspension for 30 to 60 min and then the explants were blotted dry on sterile filter papers.
  • the inoculated explants were then cultured on a co- culture medium with L-cysteine and TTD and other chemicals such as acetosyringone for increasing T-DNA delivery for 2 to 4 d.
  • the infected epicotyl explants were then placed on a shoot induction medium with selection agents such as imazapyr (for AHAS gene), glufosinate (for bar gene), or D-serine (for dsdA gene).
  • selection agents such as imazapyr (for AHAS gene), glufosinate (for bar gene), or D-serine (for dsdA gene).
  • the regenerated shoots were sub- cultured on elongation medium with the selective agent.
  • the segments were then cultured on a medium with cytokinins such as BAP, TDZ and/or Kinetin for shoot induction. After 4 to 8 weeks, the cultured tissues were transferred to a medium with lower concentration of cytokinin for shoot elongation. Elongated shoots were transferred to a medium with auxin for rooting and plant development. Multiple shoots were regenerated.
  • cytokinins such as BAP, TDZ and/or Kinetin
  • the cotyledon was removed from the hypocotyl.
  • the cotyledons were separated from one another and the epicotyl is removed.
  • the primary leaves, which consist of the lamina, the petiole, and the stipules, were removed from the epicotyl by carefully cutting at the base of the stipules such that the axillary meristems were included on the explant.
  • the explants are either completely immersed or the wounded petiole end dipped into the Agrobacterium suspension immediately after explant preparation. After inoculation, the ex- plants are blotted onto sterile filter paper to remove excess Agrobacterium culture and place explants with the wounded side in contact with a round 7 cm Whatman paper overlaying the solid CCM medium (see above). This filter paper prevents A. tumefaciens overgrowth on the soy-explants. Wrap five plates with ParafilmTM "M" (American National Can, Chicago, III., USA) and incubate for three to five days in the dark or light at 25 °C.
  • Axillary meristem explants can be pre-pared from the first to the fourth node. An average of three to four explants could be obtained from each seedling.
  • the ex- plants were prepared from plantlets by cutting 0.5 to 1.0 cm below the axillary node on the internode and removing the petiole and leaf from the explant. The tip where the axillary me- ristems lie was cut with a scalpel to induce de novo shoot growth and allow access of target cells to the Agrobacterium. Therefore, a 0.5 cm explant included the stem and a bud.
  • the explants were immediately placed in the Agrobacterium suspension for 20 to 30 minutes. After inoculation, the explants were blotted onto sterile filter paper to remove excess Agrobacterium culture then placed almost completely immersed in solid CCM or on top of a round 7 cm filter paper overlaying the solid CCM, depending on the Agrobacterium strain. This filter paper prevents Agrobacterium overgrowth on the soy-explants. Plates were wrapped with ParafilmTM "M" (American National Can, Chicago, III., USA) and incubated for two to three days in the dark at 25 °C. 3.4 - Shoot Induction
  • explants were transferred onto SIM without selection for one week.
  • leaf explants Method B
  • the explant should be placed into the medium such that it is perpendicular to the surface of the medium with the petiole imbedded into the medium and the lamina out of the medium.
  • Method C For propagated axillary meristem (Method C), the explant was placed into the medium such that it was parallel to the surface of the medium (basipetal) with the explant partially embedded into the medium. Wrap plates with Scotch 394 venting tape (3M, St. Paul, Minn., USA) were placed in a growth chamber for two weeks with a temperature averaging 25 °C under 18 h light/6 h dark cycle at 70-100 E/m 2 s. The explants remained on the SIM medium with or without selection until de novo shoot growth occurred at the target area (e.g., axillary meristems at the first node above the epicotyl). Transfers to fresh medium can occur during this time.
  • Wrap plates with Scotch 394 venting tape (3M, St. Paul, Minn., USA) were placed in a growth chamber for two weeks with a temperature averaging 25 °C under 18 h light/6 h dark cycle at 70-100 E/m 2 s.
  • Ex- plants were transferred from the SIM with or without selection to SIM with selection after about one week. At this time, there was considerable de novo shoot development at the base of the petiole of the leaf explants in a variety of SIM (Method B), at the primary node for seedling explants (Method A), and at the axillary nodes of propagated explants (Method C).
  • all shoots formed before transformation were removed up to 2 weeks after co- cultivation to stimulate new growth from the meristems. This helped to reduce chimerism in the primary transformant and increase amplification of transgenic meristematic cells.
  • the explant may or may not be cut into smaller pieces (i.e. detaching the node from the explant by cutting the epicotyl).
  • the explants were transferred to fresh SEM medium (preferably containing selection) after carefully removing dead tissue. The explants should hold together and not fragment into pieces and retain somewhat healthy. The explants were continued to be transferred until the explant dies or shoots elongate. Elongated shoots >3 cm were removed and placed into RM medium for about 1 week (Method A and B), or about 2 to 4 weeks depending on the cultivar (Method C) at which time roots began to form. In the case of explants with roots, they were transferred directly into soil. Rooted shoots were trans- ferred to soil and hardened in a growth chamber for 2 to 3 weeks before transferring to the greenhouse.
  • SEM medium preferably containing selection
  • Regenerated plants obtained using this method were fertile and produced on average 500 seeds per plant.
  • transient expression of the gene of interest (GOI) was widespread on the seedling axillary meristem explants especially in the regions wounding during explant preparation (Method A).
  • Explants were placed into shoot induction medium without selection to see how the primary-node responds to shoot induction and regeneration. Thus far, greater than 70% of the explants were formed new shoots at this region.
  • Expression of the GOI was stable after 14 days on SI M, implying integration of the T-DNA into the soy genome.
  • preliminary experiments resulted in the formation of cDNA expressing shoots forming after 3 weeks on SIM.
  • Method C the average regeneration time of a soy plantlet using the propagated axillary meristem protocol was 14 weeks from explant inoculation. Therefore, this method has a quick regeneration time that leads to fertile, healthy soy plants.
  • the plants were inoculated with spores of P. pachyrhizi.
  • soybean leaves which had been infected with rust 15-20 days ago were taken 2-3 days before the inoculation and transferred to agar plates (1 % agar in H20). The leaves were placed with their upper side onto the agar, which allowed the fungus to grow through the tissue and to produce very young spores.
  • the spores were knocked off the leaves and were added to a Tween-H20 solution. The counting of spores was performed under a light microscope by means of a Thoma counting chamber.
  • the spore suspension was added into a compressed-air operated spray flask and applied uniformly onto the plants or the leaves until the leaf surface is well moisturized.
  • a spore density 1 -5x10 5 spores/ml.
  • a density of >5 x 10 5 spores / ml is used.
  • the inoculated plants were placed for 24 hours in a greenhouse chamber with an average of 22°C and >90% of air humidity. The following cultivation was performed in a chamber with an average of 25°C and 70% of air humidity.
  • Example 5 Microscopical screening:
  • the inoculated leaves of plants were stained with aniline blue 48 hours after infection.
  • the aniline blue staining serves for the detection of fluorescent substances.
  • substances such as phenols, callose or lignin accumulated or were produced and were incorporated at the cell wall either locally in papillae or in the whole cell (hypersensitive reaction, HR).
  • Complexes were formed in association with aniline blue, which lead e.g. in the case of callose to yellow fluorescence.
  • the different interaction types were evaluated (counted) by microscopy.
  • An Olympus UV microscope BX61 (incident light) and a UV Longpath filter (excitation: 375/15, Beam splitter: 405 LP) are used. After aniline blue staining, the spores appeared blue under UV light. The papillae could be recognized beneath the fungal appressorium by a green/yellow staining.
  • the hypersensitive reaction (HR) was characterized by a whole cell fluorescence.
  • Example 6 Evaluating the susceptibility to soybean rust
  • the progression of the soybean rust disease was scored by the estimation of the diseased area (area which was covered by sporulating uredinia) on the backside (abaxial side) of the leaf. Additionally the yellowing of the leaf was taken into account (for scheme see Figure 1 ).
  • At all 50 Ti soybean plants (5 independent events, 10 plants each) expressing HCP5 protein were inoculated with spores of Phakopsora pachyrhizi.
  • the macroscopic disease symptoms of soy against P. pachyrhizi of the inoculated soybean plants were scored 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves was considered as diseased leaf area.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PCT/IB2013/056244 2012-08-09 2013-07-30 Fungal resistant plants expressing hcp5 WO2014024090A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US14/418,659 US10023875B2 (en) 2012-08-09 2013-07-30 Fungal resistant plants expressing HCP5
CA2874985A CA2874985A1 (en) 2012-08-09 2013-07-30 Fungal resistant plants expressing hcp5
BR112015002195A BR112015002195A2 (pt) 2012-08-09 2013-07-30 método para aumentar a resistência fúngica em uma planta, constructo de vetor recombinante, planta transgênica e seu método de produção, uso de qualquer um dos ácidos nucleicos, parte coletável de uma planta transgênica, produto derivado de uma planta e seu método de produção e método para criar uma planta resistente a fungos
US16/012,231 US20180291394A1 (en) 2012-08-09 2018-06-19 Fungal resistant plants expressing hcp5

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261681162P 2012-08-09 2012-08-09
EP12179862 2012-08-09
US61/681,162 2012-08-09
EP12179862.3 2012-08-09

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/418,659 A-371-Of-International US10023875B2 (en) 2012-08-09 2013-07-30 Fungal resistant plants expressing HCP5
US16/012,231 Continuation US20180291394A1 (en) 2012-08-09 2018-06-19 Fungal resistant plants expressing hcp5

Publications (2)

Publication Number Publication Date
WO2014024090A2 true WO2014024090A2 (en) 2014-02-13
WO2014024090A3 WO2014024090A3 (en) 2014-03-27

Family

ID=50068645

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/056244 WO2014024090A2 (en) 2012-08-09 2013-07-30 Fungal resistant plants expressing hcp5

Country Status (5)

Country Link
US (2) US10023875B2 (pt)
AR (1) AR093229A1 (pt)
BR (1) BR112015002195A2 (pt)
CA (1) CA2874985A1 (pt)
WO (1) WO2014024090A2 (pt)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9688999B2 (en) 2012-04-05 2017-06-27 Basf Plant Science Company Gmbh Fungal resistant plants expressing ACD
US10066239B2 (en) 2012-08-09 2018-09-04 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK2
US10231397B2 (en) 2013-01-29 2019-03-19 Basf Plant Science Company Gmbh Fungal resistant plants expressing EIN2
US10329580B2 (en) 2012-08-09 2019-06-25 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK1
US10329579B2 (en) 2011-12-23 2019-06-25 Basf Plant Science Company Gmbh Genes to enhance disease resistance in crops
US10344296B2 (en) 2012-04-05 2019-07-09 Basf Plant Science Company Gmbh Fungal resistant plants expressing hydrophobin
US10435705B2 (en) 2013-01-29 2019-10-08 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP6
US10465204B2 (en) 2013-03-08 2019-11-05 Basf Plant Science Company Gmbh Fungal resistant plants expressing MybTF
US10462994B2 (en) 2013-01-29 2019-11-05 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP7
US10494643B2 (en) 2012-04-11 2019-12-03 Basf Plant Science Company Gmbh Fungal resistant plants expressing OCP3

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10023875B2 (en) * 2012-08-09 2018-07-17 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP5
CN110229223B (zh) * 2019-06-14 2021-03-05 中国科学院遗传与发育生物学研究所 小麦抗白粉病相关bfr蛋白及其编码基因与应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101874115A (zh) * 2007-08-31 2010-10-27 巴斯夫植物科学有限公司 用于产生具有提高的植物疾病抗性的转基因植物细胞、植物或其部分的方法
CN102257144A (zh) * 2008-11-10 2011-11-23 双刃基金会 病原体可诱导的启动子及其在增强植物的疾病抗性中的用途
WO2012023111A1 (en) * 2010-08-20 2012-02-23 Basf Plant Science Company Gmbh Method of increasing resistance against fungal infection in transgenic plants by hcp-2-gene

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408896A (pt) * 2003-03-28 2006-04-25 Monsanto Technology Llc promotores de planta para uso no desenvolvimento precoce de sementes
US20060150283A1 (en) 2004-02-13 2006-07-06 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
EP2540831A3 (en) 2006-08-17 2013-04-10 Monsanto Technology, LLC Transgenic plants with enhanced agronomic traits
EP2159555B1 (de) 2008-08-25 2013-02-27 Mettler-Toledo AG Verfahren und Vorrichtung zum Füllen von Zielbehältern
US20110179523A1 (en) 2008-09-30 2011-07-21 Basf Plant Science Gmbh Method for Producing a Transgenic Plant Cell, a Plant or a Part Thereof with Increased Resistance Biotic Stress
BR112013003035B1 (pt) 2010-08-19 2020-04-22 Basf Plant Science Co Gmbh Método para aumentar resistência à ferrugem de soja,método para produzir uma planta transgênica de soja emétodo para produzir um produto
WO2012172498A1 (en) 2011-06-15 2012-12-20 Basf Plant Science Company Gmbh Method for producing transgenic plants having increased resistance to pathogens
WO2013001435A1 (en) 2011-06-27 2013-01-03 Basf Plant Science Company Gmbh Phacosporacea resistant soybean plants
US10329579B2 (en) 2011-12-23 2019-06-25 Basf Plant Science Company Gmbh Genes to enhance disease resistance in crops
WO2013092275A2 (en) 2011-12-23 2013-06-27 Basf Plant Science Company Gmbh Genes to enhance the defense against pathogens in plants
BR112014024768A2 (pt) 2012-04-05 2018-03-20 Basf Plant Science Co Gmbh método para aumentar a resistência fúngica, contructo, planta transgênica, método para a produção de uma planta transgênica, uso, parte coletável, produto, método para a produção de um produto e método para criar uma planta
BR112014021521B1 (pt) 2012-04-05 2022-05-10 Basf Plant Science Company Gmbh Método para aumentar a resistência à infecção por phakopsora em uma planta de soja transgênica, método para a produção de uma planta de soja transgênica, método para a produção de um produto e método para criar uma planta transgênica resistente a fungos
US10494643B2 (en) 2012-04-11 2019-12-03 Basf Plant Science Company Gmbh Fungal resistant plants expressing OCP3
US10023875B2 (en) * 2012-08-09 2018-07-17 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP5

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101874115A (zh) * 2007-08-31 2010-10-27 巴斯夫植物科学有限公司 用于产生具有提高的植物疾病抗性的转基因植物细胞、植物或其部分的方法
CN102257144A (zh) * 2008-11-10 2011-11-23 双刃基金会 病原体可诱导的启动子及其在增强植物的疾病抗性中的用途
WO2012023111A1 (en) * 2010-08-20 2012-02-23 Basf Plant Science Company Gmbh Method of increasing resistance against fungal infection in transgenic plants by hcp-2-gene

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10329579B2 (en) 2011-12-23 2019-06-25 Basf Plant Science Company Gmbh Genes to enhance disease resistance in crops
US10450582B2 (en) 2012-04-05 2019-10-22 Basf Plant Science Company Gmbh Fungal resistant plants expressing ACD
US11447794B2 (en) 2012-04-05 2022-09-20 Basf Plant Science Company Gmbh Method of increasing resistance to a fungal pathogen by applying a hydrophobin to a plant
US9688999B2 (en) 2012-04-05 2017-06-27 Basf Plant Science Company Gmbh Fungal resistant plants expressing ACD
US10344296B2 (en) 2012-04-05 2019-07-09 Basf Plant Science Company Gmbh Fungal resistant plants expressing hydrophobin
US10494643B2 (en) 2012-04-11 2019-12-03 Basf Plant Science Company Gmbh Fungal resistant plants expressing OCP3
US11142774B2 (en) 2012-08-09 2021-10-12 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK1
US10329580B2 (en) 2012-08-09 2019-06-25 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK1
US11180772B2 (en) 2012-08-09 2021-11-23 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK2
US10066239B2 (en) 2012-08-09 2018-09-04 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK2
US11708583B2 (en) 2012-08-09 2023-07-25 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK1
US11708584B2 (en) 2012-08-09 2023-07-25 Basf Plant Science Company Gmbh Fungal resistant plants expressing RLK2
US10435705B2 (en) 2013-01-29 2019-10-08 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP6
US10462994B2 (en) 2013-01-29 2019-11-05 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP7
US10925223B2 (en) 2013-01-29 2021-02-23 Basf Plant Science Company Gmbh Fungal resistant plants expressing EIN2
US10231397B2 (en) 2013-01-29 2019-03-19 Basf Plant Science Company Gmbh Fungal resistant plants expressing EIN2
US10465204B2 (en) 2013-03-08 2019-11-05 Basf Plant Science Company Gmbh Fungal resistant plants expressing MybTF

Also Published As

Publication number Publication date
US20180291394A1 (en) 2018-10-11
BR112015002195A2 (pt) 2017-12-12
US10023875B2 (en) 2018-07-17
AR093229A1 (es) 2015-05-27
CA2874985A1 (en) 2014-02-13
US20160040182A1 (en) 2016-02-11
WO2014024090A3 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
US11708583B2 (en) Fungal resistant plants expressing RLK1
US10941413B2 (en) Fungal resistant plants expressing CASAR
US11708584B2 (en) Fungal resistant plants expressing RLK2
US10925223B2 (en) Fungal resistant plants expressing EIN2
US10450582B2 (en) Fungal resistant plants expressing ACD
US10462994B2 (en) Fungal resistant plants expressing HCP7
US20180291394A1 (en) Fungal resistant plants expressing hcp5
US10435705B2 (en) Fungal resistant plants expressing HCP6
US10494643B2 (en) Fungal resistant plants expressing OCP3
US9944946B2 (en) Fungal resistant plants expressing HCP4
WO2014135682A1 (en) Fungal resistant plants expressing mybtf
US9957522B2 (en) Fungal resistant plants expressing CASAR
US20140047577A1 (en) Fungal Resistant Plants Expressing RLK2
US20140047578A1 (en) Fungal Resistant Plants Expressing HCP5
US20140047576A1 (en) Fungal Resistant Plants Expressing HCP4

Legal Events

Date Code Title Description
ENP Entry into the national phase in:

Ref document number: 2874985

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14418659

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 13827972

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112015002195

Country of ref document: BR

ENP Entry into the national phase in:

Ref document number: 112015002195

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20150130

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: 112015002195

Country of ref document: BR

Kind code of ref document: A2

ENP Entry into the national phase in:

Ref document number: 112015002195

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20150130